GT,Diagnosis 1,ERN Category
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Hallmark symptoms of death in infancy/childhood, metabolic acidosis, and diagnostic finding of decreased methylmalonyl-CoA mutase activity. Other typical symptoms that were not reported include poor feeding, vomiting, lethargy, and developmental delay.

2. Propionic acidemia: Can also present with death in infancy, metabolic acidosis, and potentially decreased methylmalonyl-CoA mutase activity. However, methylmalonic acidemia is more likely given the specific enzyme deficiency noted.

3. Disorders of cobalamin metabolism (e.g. cblA, cblB, cblC, cblD): Defects in cobalamin (vitamin B12) metabolism can impair methylmalonyl-CoA mutase activity and cause a similar clinical picture as methylmalonic acidemia. Additional findings may include megaloblastic anemia, hyperhomocysteinemia, and methylmalonic aciduria.

4. MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes): This mitochondrial disorder can present in childhood with metabolic acidosis and early death, but would typically have additional neurologic symptoms like seizures, stroke-like episodes, and muscle weakness. Methylmalonic acidemia is much more likely in this case.

5. Pyruvate dehydrogenase deficiency: Another metabolic disorder that can present with lactic acidosis and early childhood death. However, patients typically have severe neurologic dysfunction, seizures, and structural brain abnormalities. Less likely than methylmalonic acidemia given this patient's presentation and diagnostic studies.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Consistent with motor delay, hypotonia, elevated urinary carboxylic acid, and potential for metabolic crisis and early death. Additional symptoms may include macrocephaly and dystonia.

2. Propionic acidemia: Matches the motor delay, hypotonia, elevated carboxylic acid, and risk of early death, often due to metabolic decompensation and complications like pneumonia. Other symptoms may include poor feeding, vomiting, and lethargy.  

3. Zellweger spectrum disorder: Explains the hypotonia, motor delay, elevated carboxylic acid, and early death. Patients may also have distinctive facial features, seizures, and liver dysfunction.

4. Spinal muscular atrophy type 1: The most severe form could cause infantile hypotonia, weakness, motor delay, and early death, often related to respiratory issues like pneumonia. However, it would not explain the abnormal carboxylic acid finding.

5. Pompe disease (glycogen storage disease type II): The infantile-onset form is characterized by hypotonia, muscle weakness, motor delay, cardiomegaly, and early death, but urinary carboxylic acid is not typically elevated.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurologic crises. Can lead to death in infancy if untreated. Patient's hypertyrosinemia is consistent, but liver and kidney involvement are not mentioned.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and severe intellectual disability if untreated. Screened for at birth in many places. Patient has hyperphenylalaninemia but no mention of developmental delay or intellectual disability, which are key features.

3. Maple syrup urine disease: Disorder of branched-chain amino acid metabolism causing poor feeding, vomiting, lethargy, and maple syrup odor to urine. Can be fatal in neonatal period if unrecognized. Elevated branched-chain amino acids are not reported in this patient.

4. Homocystinuria: Defect in methionine metabolism leading to elevated homocysteine and methionine. Can cause developmental delay, eye problems, skeletal abnormalities, and thromboembolism. Patient's amino acid abnormalities do not fit this diagnosis.

5. Zellweger syndrome: Peroxisomal biogenesis disorder causing craniofacial abnormalities, hypotonia, seizures, and liver dysfunction. Often fatal in first year of life. Additional tests like very long chain fatty acids and plasmalogens could help rule this in or out.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Congenital central hypoventilation syndrome (CCHS): Characterized by impaired breathing drive due to abnormal development of the autonomic nervous system. Consistent with diaphragmatic hernia, failure to thrive, and risk of infant death. Other features like cerebellar issues are not typical.

2. Dandy-Walker malformation: A congenital brain malformation involving the cerebellum and surrounding structures. Matches cerebellar agenesis/atrophy and motor delay. May be associated with other congenital defects like diaphragmatic hernia. Does not fully explain the lipodystrophy and muscle abnormalities.

3. Zellweger spectrum disorder: A group of rare metabolic disorders causing impaired peroxisome function. Can present with lipodystrophy, abnormal muscle tone, failure to thrive, and neurological abnormalities including cerebellar dysfunction. Severe cases can be fatal in infancy. Diaphragmatic hernia is not a classic feature.

4. Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME): A rare neurodegenerative disorder characterized by muscle weakness, seizures, and cerebellar degeneration. Could explain the motor delay, cerebellar atrophy, abnormal muscle physiology, and infant death. Lipodystrophy and diaphragmatic defects are not typically seen.

5. Mitochondrial DNA depletion syndrome: A group of genetic disorders causing impaired mitochondrial function and energy production. Can affect multiple systems, including the brain, muscles, and GI tract. Might account for the cerebellar issues, motor delay, failure to thrive, lipodystrophy, and muscle abnormalities. Diaphragmatic hernias are not a classic finding.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: Characterized by intellectual disability, motor delay, generalized hypotonia, feeding difficulties, opisthotonus, athetosis, and elevations of branched-chain amino acids (valine, leucine, isoleucine). Can be associated with kyphoscoliosis. The patient's elevated urinary carboxylic acid also fits. Fever is not typically seen.

2. Cerebral palsy: Could explain the motor delay, intellectual disability, generalized hypotonia, opisthotonus, athetosis, and feeding difficulties. Delayed speech and kyphoscoliosis can also be seen. However, this would not account for the metabolic abnormalities.

3. Glutaric aciduria type 1: Features acute neurological crises often triggered by fever, opisthotonus, intellectual disability, motor delay, and elevated urinary organic acids. Generalized hypotonia is not typical and branched-chain amino acids are usually normal.

4. Lesch-Nyhan syndrome: X-linked disorder characterized by intellectual disability, motor delay, generalized hypotonia, and opisthotonus. Athetosis and kyphoscoliosis can occur. However, the hallmark is self-injurious behavior, which was not described here. Metabolic abnormalities involve purine metabolism.

5. Leigh syndrome: Mitochondrial disorder that can present with motor delay, intellectual disability, generalized hypotonia, athetosis, and episodes of fever and opisthotonus. Elevated lactate and specific MRI brain abnormalities are usually seen. Branched-chain amino acids and urinary organic acids are typically normal.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Hyperphenylalaninemia, skin rash, gastrointestinal issues, abnormal development, and early death are consistent with untreated PKU. However, this patient also has hypertyrosinemia which is not typical of PKU.

2. Tyrosinemia type I: Hypertyrosinemia, failure to thrive, gastrointestinal inflammation, diarrhea, and risk of early death fit with tyrosinemia type I. Skin findings and recurrent infections are not classic features.

3. Severe combined immunodeficiency (SCID): Recurrent viral infections starting in infancy and early mortality are hallmarks of SCID. Additional features like failure to thrive and diarrhea can occur. However, the metabolic abnormalities and rash are not typical of SCID.

4. Netherton syndrome: Erythematous skin rash, failure to thrive, recurrent infections, and gastrointestinal issues can be seen in Netherton syndrome, a rare genetic skin disorder. The metabolic disturbances would be atypical.

5. Propionic acidemia: This inherited metabolic disorder can present in infancy with poor feeding, vomiting, lethargy, failure to thrive, and risk of early death. Skin rash and recurrent infections are possible secondary complications. Specific metabolites on newborn screening would be expected.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Mitochondrial disorder: The increased lactate in blood and CSF is a key finding that suggests a mitochondrial disorder. The skin rash and alopecia could be related. Symptoms not reported include muscle weakness, developmental delays, seizures, and vision/hearing problems.

2. Netherton syndrome: This rare genetic skin disorder is characterized by eczematoid dermatitis, skin rash, alopecia, and failure to thrive in infancy which can lead to death. Key symptom not reported is abnormal hair shafts.

3. Autoimmune disorder: The skin rash, alopecia, and eczematoid dermatitis could be manifestations of an autoimmune condition like lupus, dermatomyositis, or scleroderma. The increased lactate is atypical. Additional symptoms of autoimmune diseases may include joint pain, fever, and organ involvement.

4. Propionic acidemia: This inherited metabolic disorder can present in infancy with skin rash, alopecia, metabolic acidosis with increased lactate, and potentially death if untreated. Symptoms not reported include vomiting, lethargy, seizures, and developmental delays.

5. Neonatal sclerosing cholangitis: This rare liver disorder presents in infancy with skin rash, alopecia, failure to thrive, and elevated lactate due to liver dysfunction. Death can occur from progressive liver disease. Jaundice and hepatomegaly are key features not reported.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Zellweger spectrum disorder: Matches the patient's intellectual disability, liver dysfunction, vision impairment, and facial dysmorphism. Can also cause low muscle tone and seizures, which were not mentioned.

2. Niemann-Pick disease type C: Explains the cerebellar atrophy, intellectual decline, liver disease, and abnormal eye movements (if present). Does not typically cause skeletal abnormalities.  

3. Congenital disorders of glycosylation: A group of disorders that can present with cerebellar hypoplasia, developmental delay, vision impairment, and liver dysfunction. Additional symptoms may include failure to thrive and low blood sugar.

4. Aicardi-Gouti√®res syndrome: An inflammatory disease associated with intellectual impairment, liver dysfunction, thrombocytopenia, and skin lesions. Calcifications in the brain are a hallmark but were not noted here.

5. Neonatal hemochromatosis: A rare disorder of iron metabolism causing liver failure, with potential brain iron accumulation. Matches the liver disease but would not expect the eye, bone or lipodystrophy symptoms.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Consistent with glutaric aciduria, macrocephaly, dystonia, dyskinesia, and risk of metabolic crisis and early death. Additional symptoms can include subdural hematoma and dehydration.

2. Pyruvate dehydrogenase deficiency: Hypotonia, lethargy, poor feeding, and lactic acidosis are common. Dysmorphic features may be present. Can be fatal in infancy.

3. Zellweger syndrome (a peroxisomal biogenesis disorder): Presents with hypotonia, poor feeding, distinctive facial features, and hepatic dysfunction. Seizures and bony abnormalities are also seen.

4. Molybdenum cofactor deficiency: Characterized by neonatal seizures, hypotonia, and dysmorphic facial features. Feeding difficulties and high risk of early death are typical. 

5. Menkes disease: Key features include hypotonia, seizures, failure to thrive, and kinky, sparse hair. Hypothermia and bladder diverticula may occur. Usually fatal in early childhood.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Consistent with hyperammonemia, lethargy, feeding problems, and risk of infant death. May also have ketoacidosis and hypoglycemia.

2. Methylmalonic acidemia: Also features hyperammonemia, lethargy, poor feeding, and high mortality. Megaloblastic anemia and neutropenia may be present.  

3. Urea cycle disorders (e.g. OTC deficiency, CPS deficiency): The hyperammonemia, lethargy, and childhood mortality fit. Additional symptoms may include vomiting, seizures, and cerebral edema.

4. Non-ketotic hyperglycinemia: Matches the abnormal glycine levels, lethargy, and infant death. Seizures and severe hypotonia are often seen.

5. Carnitine uptake defect: The abnormal carnitine levels, drowsiness and early death are consistent. Typically also causes cardiomyopathy and hypoglycemia.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by cerebellar vermis hypoplasia, hypotonia, ataxia, developmental delays, and eye movement abnormalities. Matches the patient's cerebellar findings, hypotonia, ataxia, and eye signs, but this patient has more severe features.

2. Walker-Warburg syndrome: Includes brain malformations (lissencephaly, cerebellar abnormalities), eye anomalies, intellectual disability, seizures, and hypotonia. Fits with microcephaly, cerebellar issues, eye findings, intellectual disability and hypotonia. Patient is missing lissencephaly and seizures.

3. Pontocerebellar hypoplasia: Presents with microcephaly, severe developmental delays, hypotonia, and cerebellar hypoplasia/atrophy. Matches microcephaly, cerebellar atrophy, motor delay, intellectual disability, and hypotonia. Additional spinal cord involvement is often seen.

4. Trisomy 13: Features intellectual disability, microcephaly, hypotonia, eye defects, and brain malformations. Consistent with microcephaly, intellectual disability, hypotonia, and eye movement disorders. Other typical findings (cleft lip/palate, polydactyly, heart defects) not reported.

5. Zellweger spectrum disorder: Includes cerebellar hypoplasia, hypotonia, seizures, vision/hearing impairment, and early death. Matches cerebellar abnormality, hypotonia, encephalopathy, and death in infancy. Typical liver dysfunction and facial features not mentioned.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","1. Methylmalonic acidemia: Consistent with methylmalonic aciduria, hyperammonemia, metabolic/lab abnormalities, developmental delay, and high mortality. Does not explain eye findings.

2. Homocystinuria: Accounts for hyperhomocystinemia, eye abnormalities, developmental delay, and possible cardiac defect. Other metabolic abnormalities and acidurias are not typical.

3. Propionic acidemia: Could explain hyperammonemia, cardiomyopathy, metabolic abnormalities, and high mortality. Eye findings and hyperhomocystinemia are atypical.  

4. Zellweger spectrum disorder: Peroxisomal biogenesis disorder that can present with hypotonia, developmental delay, vision/hearing impairment, and liver dysfunction. Specific metabolic abnormalities are not classic.

5. Glutaric aciduria type 1: Can cause metabolic crisis, hypotonia, and brain atrophy. Typical presentation also includes macrocephaly and basal ganglia injury. Eye findings and other metabolic abnormalities are not characteristic.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Presents with hypoglycemia, vomiting, and lethargy in infancy. Can be life-threatening. Key feature is inability to break down medium-chain fatty acids for energy during fasting.

2. Propionic acidemia: An organic acid disorder causing acute deterioration, hypoglycemia, vomiting, and death in infancy if untreated. Marked by toxic buildup of propionic acid. Lethargy/coma is common which was not reported here.

3. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Another disorder of fatty acid metabolism, typically presents in infancy with hypoglycemia, liver dysfunction, and cardiomyopathy (not reported). 

4. Glutaric aciduria type II: A severe metabolic condition causing weakness, hypoglycemia, and metabolic acidosis in infancy. Can have liver enlargement and dysfunction. Distinct urine organic acid profile.

5. Carnitine uptake defect (primary carnitine deficiency): Leads to defective fatty acid oxidation. Causes hypoglycemia, hepatic encephalopathy, and cardiomyopathy (not reported) in infancy. Low plasma carnitine is a key finding.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with neonatal presentation, coma, respiratory acidosis, hyperkalemia, and elevated urinary carboxylic acid (specifically 3-hydroxypropionate and methylcitrate). May also have hypoglycemia and hyperammonemia, which were not reported.

2. Methylmalonic acidemia: Matches the symptoms of neonatal onset, coma, respiratory acidosis, hyperkalemia, and increased urinary carboxylic acid (methylmalonic acid). Additional features may include hypoglycemia, neutropenia, and thrombocytopenia.

3. Isovaleric acidemia: Aligns with the findings of coma, respiratory acidosis, hyperkalemia, and elevated urinary carboxylic acid (isovalerylglycine). The patient may also have a characteristic ""sweaty feet"" odor, which was not mentioned.

4. Glutaric acidemia type II: Consistent with neonatal presentation, coma, respiratory acidosis, and increased urinary carboxylic acids. May also exhibit hypoglycemia, hyperammonemia, and organic aciduria with dicarboxylic acids.

5. Maple syrup urine disease: Matches the symptoms of neonatal onset, coma, respiratory acidosis, and hyponatremia. Elevated urinary branched-chain amino acids and their ketoacids would be expected, rather than the reported carboxylic acid. The characteristic sweet, maple syrup-like odor may also be present.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria: Ptosis, ectopia lentis, intellectual disability, long limbs, hyperhomocystinemia, and early death are all consistent with this diagnosis. The hypermethioninemia also fits.

2. Marfan syndrome: The patient's ptosis, ectopia lentis, long limbs, and skeletal features could fit this connective tissue disorder. However, the metabolic abnormalities and intellectual disability would be atypical.

3. Sulfite oxidase deficiency: This rare disorder can cause ectopia lentis, intellectual disability, and early death. The patient's other features are less typical.

4. Congenital disorder of glycosylation: Some forms can involve multisystem issues including eye findings, skeletal abnormalities, intellectual disability, and metabolic disturbances. More specific findings would be expected.

5. Stickler syndrome: The eye findings could fit this connective tissue disorder, but the other features, especially the metabolic abnormalities and intellectual disability, would be unusual.",Hereditary metabolic disorders
[],"1. Leigh syndrome: Consistent with seizures, feeding difficulties, and early mortality. Key features not mentioned include developmental regression, muscle weakness, and lactic acidosis.

2. Zellweger syndrome: Matches facial dysmorphism, seizures, and neonatal/infant death. Other common symptoms include severe hypotonia, liver dysfunction, and vision/hearing impairment.  

3. Pyruvate dehydrogenase deficiency: Explains seizures, hypoglycemia, lactic acidosis, and early death. Developmental delay is another key feature.

4. Tay-Sachs disease: Fits with seizures, developmental regression, vision loss, and death in early childhood. Cherry-red spot on retinal exam is a hallmark sign.

5. Mucopolysaccharidosis type 1: Coarse facial features, sparse hair, frequent respiratory infections, and developmental delays are typical. Corneal clouding and skeletal abnormalities are also common.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Symptoms consistent with this diagnosis include intellectual disability, seizures, anemia, hyperammonemia, and abnormal carnitine levels. Key features not mentioned include vomiting, lethargy, ketoacidosis, and odd odor.

2. Methylmalonic acidemia: Matches the patient's intellectual disability, seizures, anemia, hepatomegaly, and hyperammonemia. Additional symptoms can include vomiting, dehydration, ketoacidosis, and kidney problems.

3. Glycine encephalopathy (nonketotic hyperglycinemia): Aligns with the abnormal prenatal development, intellectual disability, seizures, hypotonia, and notably the hyperglycinemia. Other features may include myoclonic jerks, apnea, and EEG abnormalities.  

4. Isovaleric acidemia: Could explain the intellectual disability, seizures, anemia, and hyperammonemia. Typical symptoms not reported include vomiting, odor of ""sweaty feet"", and ketoacidosis during acute episodes.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: Less likely, but potentially fits the intellectual disability, seizures, and childhood mortality. Usually presents with episodes of vomiting, lethargy, hypoglycemia, and ketosis. Abnormal carnitine levels can be seen.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Generalized hypotonia, metabolic acidosis, decreased methylmalonyl-CoA mutase activity, methylmalonic aciduria, thrombocytopenia, leukopenia, feeding difficulties, apnea, neonatal death. Key features not reported include hyperammonemia, ketoacidosis, and renal failure.

2. Propionic acidemia: Generalized hypotonia, metabolic acidosis, thrombocytopenia, leukopenia, feeding difficulties, apnea, neonatal death. However, methylmalonic aciduria and decreased methylmalonyl-CoA mutase activity are not typical of propionic acidemia.

3. Severe combined immunodeficiency (SCID): Thrombocytopenia, leukopenia, feeding difficulties, death in infancy. SCID does not usually cause the metabolic abnormalities seen in this patient.

4. Zellweger syndrome (a peroxisomal disorder): Generalized hypotonia, apnea, feeding difficulties, thrombocytopenia, leukopenia, neonatal death. Zellweger syndrome is not associated with methylmalonic aciduria or decreased methylmalonyl-CoA mutase activity.

5. Molybdenum cofactor deficiency: Metabolic acidosis, feeding difficulties, abnormal nervous system physiology, neonatal death. Key features not reported include seizures, dysmorphic facial features, and dislocated lenses. Methylmalonic aciduria is also not characteristic of this disorder.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"1. Fatty acid oxidation disorder: Consistent with hypoglycemia, sudden death, decreased carnitine, and abnormal amino acids. May not explain the elevated alkaline phosphatase.

2. Organic acidemia (e.g. propionic acidemia, methylmalonic acidemia): Fits with the hypoglycemia, vomiting, abnormal amino acids, and risk of sudden death. Urine organic acids could confirm.

3. Urea cycle disorder: The hyperammonemia could cause vomiting, lethargy progressing to coma, and risk of death. Plasma amino acids may show elevated citrulline or arginine depending on the specific defect.  

4. Mitochondrial disorder: Could explain the hypoglycemia, lactic acidosis (elevated lactate dehydrogenase), and multi-system involvement. Muscle biopsy may show abnormal mitochondria.

5. Galactosemia: Build-up of galactose-1-phosphate can cause vomiting, hypoglycemia, hepatic dysfunction (elevated alkaline phosphatase), and risk of neonatal death if untreated. Newborn screening is diagnostic.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Lethargy, drowsiness, poor feeding, low carnitine levels. May also have hypoglycemia, vomiting, and liver dysfunction.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Poor feeding, lethargy, hypotonia, cardiomyopathy, low carnitine. Rhabdomyolysis and liver disease may occur. 

3. Glutaric aciduria type 2: Feeding difficulties, lethargy, hypotonia, coma, metabolic acidosis, low carnitine, organic aciduria. Distinctive odor may be present.

4. Mitochondrial trifunctional protein deficiency: Lethargy, hypotonia, cardiomyopathy, metabolic acidosis, liver dysfunction, low carnitine. Peripheral neuropathy and pigmentary retinopathy may develop later.

5. Carnitine-acylcarnitine translocase deficiency: Poor feeding, vomiting, lethargy progressing to coma, severe hypoglycemia, hyperammonemia, liver dysfunction. Presents in the neonatal period.",Hereditary metabolic disorders
[],"1. Ethylmalonic encephalopathy: Characterized by delayed development, dysarthria, spasticity, seizures, ethylmalonic aciduria, and recurrent infections. Key features not reported include acrocyanosis, petechiae, chronic diarrhea.

2. MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes): Explains developmental delays, spasticity, hyperreflexia, and COX-negative fibers. Other common symptoms include seizures, headaches, vomiting, hearing loss, diabetes.

3. Nonketotic hyperglycinemia: Presents with hypotonia, seizures, spasticity, and developmental delays. Elevated CSF and plasma glycine levels are diagnostic. Absence of seizures in this patient makes it less likely.

4. Cerebral folate deficiency: Can cause delayed development, spasticity, dysarthria, seizures, and recurrent infections. Low CSF levels of 5-methyltetrahydrofolate are diagnostic. Hypothyroidism is not typically seen.

5. Infantile spasm syndrome (West syndrome): Characterized by developmental delay, spastic quadriplegia, and clustered flexor spasms. EEG shows hypsarrhythmia. Hypothyroidism and metabolic abnormalities are not typical features.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Characterized by macrocephaly, neurological symptoms (hypotonia, dystonia, dyskinesia), glutaric aciduria, elevated glutaric acid, and risk of early death. Key features not reported include encephalopathic crises and brain atrophy/abnormalities on imaging.

2. Canavan disease: Presents with macrocephaly, hypotonia, lethargy, and early death. Elevated N-acetylaspartic acid would be expected rather than glutaric aciduria.

3. Niemann-Pick disease type C: Can cause dystonia, lethargy, hypotonia, and developmental regression. Lacks the specific metabolic findings seen in this patient. Vertical supranuclear gaze palsy is a key feature not reported.

4. Leigh syndrome: Causes hypotonia, dystonia, developmental regression, and early death. Elevated lactate and specific brain imaging findings would be expected. Glutaric aciduria is not typical.

5. Alexander disease: Presents with macrocephaly, hypotonia, seizures, and early death. Elevated CSF alpha-B-crystallin and brain imaging abnormalities are characteristic features not reported here.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause failure to thrive, liver disease, and early death if untreated. Other symptoms like hyperphenylalaninemia and abnormal development are consistent. 

2. Phenylketonuria (PKU): A disorder of phenylalanine metabolism causing hyperphenylalaninemia and brain damage. Fits with abnormal development but hypertyrosinemia is not typical. Usually not fatal in infancy/childhood with treatment.

3. Maple syrup urine disease: A metabolic disorder that can present with poor feeding, lethargy, and developmental delay in infancy. Can be life-threatening but hypertyrosinemia is not characteristic.

4. Zellweger spectrum disorders: Group of congenital disorders causing severe neurological dysfunction, liver disease, and early death. Some cases have abnormal tyrosine or phenylalanine levels. Additional symptoms may include distinctive facial features and vision/hearing problems.

5. Molybdenum cofactor deficiency: Rare metabolic disorder that can cause seizures, brain damage and early death. Involves sulfite oxidase deficiency which can lead to some amino acid abnormalities. Other key features are missing like lens dislocation.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. Krabbe disease: Delayed development, intellectual disability, difficulty walking/climbing stairs, hyperreflexia, abnormal white matter, early death. Key features not mentioned include vision loss, seizures, and peripheral neuropathy.

2. Metachromatic leukodystrophy: Developmental delays, intellectual decline, gait difficulties, hyperreflexia, abnormal cerebral white matter, death often by late childhood. Lacking mention of seizures, vision/hearing loss, and behavioral changes.

3. Canavan disease: Delayed development, intellectual disability, difficulty walking, abnormal white matter, early death. Missing features include macrocephaly, hypotonia, and seizures.

4. Alexander disease: Developmental delays, intellectual regression, hyperreflexia, difficulty walking/climbing, abnormal white matter, death in childhood. Key symptoms not reported are seizures, macrocephaly, and spasticity.

5. Pelizaeus-Merzbacher disease: Delayed motor and language milestones, intellectual disability, abnormal white matter, shortened lifespan. Spasticity, nystagmus, and ataxia are notable features not described in this patient.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Characterized by elevated branched-chain amino acids (hypervalinemia, hyperleucinemia, hyperisoleucinemia), neurological symptoms (hypotonia, spasticity), hypoglycemia, and high mortality. The patient's apathy and obesity are also consistent with MSUD.

2. Propionic acidemia: Can present with hypotonia, metabolic acidosis, hypoglycemia, and lethargy. Elevated propionylcarnitine on newborn screening would support this diagnosis.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with hypotonia, metabolic acidosis, hypoglycemia, and lethargy. Elevated methylmalonic acid in urine would distinguish it from propionic acidemia.

4. Isovaleric acidemia: Another organic acidemia that can cause hypotonia, lethargy, and failure to thrive. The characteristic ""sweaty feet"" odor was not mentioned by the patient.

5. Glutaric acidemia type 1: Typically presents with macrocephaly, which the patient does not have. Can also cause hypotonia and dystonia. Elevated glutaric acid in urine is diagnostic.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Explains the hypergalactosemia, liver dysfunction (increased bilirubin), aminoaciduria, and risk of early death. Speech delays and intellectual disability are common. Key symptom not reported: cataracts.

2. Tyrosinemia type I: Accounts for the elevated tyrosine, liver problems, and risk of early death. Can cause intellectual disability and developmental delays. Not specifically mentioned: renal tubular dysfunction, peripheral neuropathy.

3. Phenylketonuria (PKU): Characterized by high phenylalanine levels which can present as hyperalaninemia. Untreated PKU causes severe intellectual disability, developmental delays, and seizures. Missing symptom: musty body odor.

4. Fructose intolerance: A disorder of fructose metabolism that can present with liver dysfunction, aminoaciduria, and early mortality. Developmental delays are possible. Lacking symptom: aversion to sweets and fruits.

5. Niemann-Pick disease type C: A lysosomal storage disorder that can feature developmental delays, intellectual decline, liver dysfunction, and childhood death. Vertical gaze palsy is a hallmark sign not mentioned here.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Symptoms consistent with patient presentation include metabolic acidosis, hyperammonemia, vomiting, and 3-methylglutaric aciduria. Can present in infancy with poor feeding, lethargy, and death if untreated.

2. Methylmalonic acidemia: Also features metabolic acidosis, hyperammonemia, vomiting, and 3-methylglutaric aciduria. Severe cases can present in early infancy with metabolic decompensation.

3. Isovaleric acidemia: Characterized by periodic vomiting, metabolic acidosis, and a distinctive ""sweaty feet"" odor not mentioned in this patient. 3-methylglutaric aciduria can be seen.

4. Glutaric acidemia type 1: Typically presents in infancy with metabolic acidosis, dystonia, and brain atrophy. Dicarboxylic aciduria is a key finding. No mention of dystonia in this patient.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: Can cause metabolic acidosis, hyperammonemia, hypoglycemia, and 3-methylglutaric aciduria. Usually presents later in infancy or childhood compared to the other conditions.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria: Characterized by elevated homocysteine and neurologic deterioration. Other features like lens dislocation, marfanoid habitus not reported.

2. Methylenetetrahydrofolate reductase (MTHFR) deficiency: Causes hyperhomocysteinemia, hypomethioninemia, and abnormal folate metabolism leading to neurologic deficits. Hematologic and immune symptoms are less typical.

3. Acute intermittent porphyria: Presents with neurologic symptoms, jaundice, anemia, and abnormal porphyrin levels. Usually has later onset but congenital erythropoietic porphyria can occur in childhood.

4. Congenital disorder of glycosylation type Ia: Can involve hypotonia, neurologic deterioration, hepatic dysfunction, coagulopathy and failure to thrive in infancy. Characteristic abnormal glycosylation of transferrin is not mentioned.

5. Severe combined immunodeficiency (SCID): Accounts for recurrent infections and early mortality. Neurologic and metabolic abnormalities are not typical of SCID.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, abnormal development, high mortality in infancy/childhood due to liver failure or hepatocellular carcinoma. Can also cause renal dysfunction.

2. Phenylketonuria (PKU): Hyperphenylalaninemia, intellectual disability if untreated. Usually does not cause structural birth defects or airway issues.

3. Maple syrup urine disease (MSUD): Inborn error of branched-chain amino acid metabolism, can present in the neonatal period with poor feeding, vomiting, lethargy progressing to coma and death if untreated. Sweet-smelling urine.

4. Congenital central hypoventilation syndrome (CCHS): Rare disorder of respiratory control leading to chronic hypoventilation and pulmonary obstruction/infection. Can be associated with Hirschsprung disease, tumors of the nervous system. High mortality.

5. Tracheal agenesis or severe tracheal stenosis: Rare congenital malformations causing upper airway obstruction from birth. Tracheal agenesis is usually fatal in the neonatal period. Tracheal stenosis has a poor prognosis without surgical intervention.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with seizures, spasticity, elevated urinary carboxylic acid, and potential for death in infancy. Key symptoms not reported include vomiting, lethargy, and metabolic acidosis.

2. Methylmalonic acidemia: Matches the neurological symptoms, elevated urinary carboxylic acid, and risk of infant death. Additional symptoms may include vomiting, dehydration, and hepatomegaly.

3. Isovaleric acidemia: Aligns with apathy, seizures, elevated urinary carboxylic acid, and fatigue. The patient did not report the characteristic ""sweaty feet"" odor.

4. Glutaric acidemia type 1: Explains the neurological symptoms and elevated urinary carboxylic acid. Macrocephaly is a key feature not mentioned by the patient.

5. Multiple carboxylase deficiency: The combination of neurological symptoms, alopecia, and elevated urinary carboxylic acid fits this diagnosis. Skin rash and conjunctivitis are additional characteristic symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, hyperphenylalaninemia, liver dysfunction, renal tubular dysfunction, and risk of hepatocellular carcinoma. Consistent with patient's hypertyrosinemia, hyperphenylalaninemia, and family history of early deaths.

2. Phenylketonuria (PKU): Caused by deficiency of phenylalanine hydroxylase leading to elevated phenylalanine levels. Classic form presents in infancy with failure to thrive, microcephaly, global developmental delay, and untreated has risk of intellectual disability. Consistent with hyperphenylalaninemia but patient's obesity and lack of reported developmental issues make this less likely.

3. Hereditary tyrosinemia type II: Presents with hypertyrosinemia, eye and skin lesions, and intellectual disability. Consistent with patient's hypertyrosinemia but lacks other key features.

4. Alkaptonuria: Disorder of tyrosine metabolism with accumulation of homogentisic acid. Characterized by darkening of urine, ochronosis, and arthritis in adulthood. Patient's young age and lack of reported dark urine make this unlikely.

5. Acute fatty liver of pregnancy: Rare but potentially fatal disorder of pregnancy. Can present with nausea, vomiting, abdominal pain, jaundice, and elevated liver enzymes. Patient's age and lack of reported pregnancy make this unlikely but it could potentially explain gastrointestinal symptoms and family history of deaths in a pregnant female relative.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with skin rash, metabolic acidosis, increased CSF lactate, aminoaciduria, and elevated urinary carboxylic acid. Can be life-threatening in infancy.

2. Methylmalonic acidemia: Presents with similar metabolic abnormalities as propionic acidemia, including acidosis, elevated glycine, and increased urinary organic acids. Severe cases can lead to early death.

3. Non-ketotic hyperglycinemia: Characterized by abnormal glycine metabolism leading to elevated CSF and plasma glycine. Can cause severe symptoms in infancy. Additional symptoms may include hypotonia and seizures, which were not reported in this case.

4. Holocarboxylase synthetase deficiency: A disorder of biotin metabolism leading to organic acidemia, metabolic acidosis, and skin rash. Alopecia is not a typical feature.

5. Canavan disease: A leukodystrophy that can present in infancy with poor feeding, hypotonia, macrocephaly, and increased CSF lactate. The skin findings and alopecia would be atypical.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Hallmark finding of decreased methylmalonyl-CoA mutase activity. Explains infant death, neonatal death, feeding difficulties, and dehydration.

2. Propionic acidemia: Can also present with decreased methylmalonyl-CoA mutase activity, infant death, poor feeding, and dehydration. Lethargy and hyperammonemia are common.

3. Disorders of cobalamin metabolism (e.g. cblA, cblB, cblC, cblD): Impaired synthesis of adenosylcobalamin, a cofactor for methylmalonyl-CoA mutase, leading to methylmalonic acidemia and symptoms in infancy. 

4. Neonatal sepsis: Life-threatening bloodstream infection that can cause feeding difficulties, dehydration, lethargy, and rapid clinical deterioration in infants. Does not explain decreased methylmalonyl-CoA mutase activity.

5. Transient neonatal hyperammonemia: Causes lethargy, poor feeding, and vomiting in newborns due to immature liver function. Usually self-resolves. Decreased methylmalonyl-CoA mutase activity and infant death would be atypical.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with propionyl-CoA carboxylase deficiency, metabolic acidosis, increased glycine, lethargy, hypotonia, and elevated urinary carboxylic acids. Can be life-threatening in infancy.

2. Pyruvate dehydrogenase complex deficiency: Fits with lactic acidosis, metabolic acidosis, decreased pyruvate metabolism, neurological symptoms, and early mortality. Fever is atypical.

3. Methylmalonic acidemia: Can explain metabolic acidosis, lethargy, hypotonia, elevated glycine and other amino acids, and complications like gangrene. Propionyl-CoA carboxylase activity would be normal.

4. Glutaric acidemia type II: Multiple acyl-CoA dehydrogenase deficiency causing acidosis, hypotonia, and carboxylic aciduria. Usually presents with hypoglycemia and hepatomegaly as well.

5. MELAS syndrome: Mitochondrial disorder with lactic acidosis, metabolic strokes, and neurological deterioration. Onset is usually later in childhood or adulthood however.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Consistent with hypertyrosinemia, abnormality of prenatal development, and early death. May also have symptoms not reported like liver failure, kidney dysfunction, and rickets.

2. Phenylketonuria (PKU): Matches hyperphenylalaninemia and can cause abnormal development and intellectual disability if untreated. However, early death is less common than in tyrosinemia.

3. Maple syrup urine disease: Can cause neonatal death and severe neurological symptoms due to buildup of branched-chain amino acids. Characteristic odor of urine not reported.

4. Homocystinuria: Inborn error of methionine metabolism that can cause developmental delay, eye problems, and thromboembolic events. Can be fatal but less commonly in infancy compared to tyrosinemia.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing abnormal development, hypotonia, seizures, and early death. May have additional symptoms like distinctive facial features and liver dysfunction.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. 3-Methylglutaconic aciduria type I: Caused by 3-methylglutaconyl-CoA hydratase deficiency. Consistent with patient's 3-methylglutaric aciduria, dicarboxylic aciduria, and early death.

2. Glutaric acidemia type II: Disorder of fatty acid oxidation and amino acid catabolism. Matches dicarboxylic aciduria and elevated urinary carboxylic acid. Can present in infancy with severe symptoms.

3. Canavan disease: Deficiency of aspartoacylase leading to buildup of N-acetylaspartic acid. Presents in infancy with progressive neurologic deterioration, often leading to early death. Elevated urinary dicarboxylic acids can be seen.

4. Propionic acidemia: Defect in propionyl-CoA carboxylase. Can present in infancy with lethargy, vomiting, metabolic acidosis, and early death if untreated. Elevated 3-methylglutaric acid and other urinary organic acids.

5. Leigh syndrome: Mitochondrial disorder disrupting energy production. Causes progressive neurologic decline starting in infancy. Can have elevated lactate, pyruvate and organic acids. Typical symptoms of developmental delay, seizures, and movement disorders not reported in this patient.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson's disease: Characterized by decreased ceruloplasmin and copper, increased urinary copper excretion, liver dysfunction (elevated transaminases), and neuropsychiatric symptoms. Carious teeth have been reported. Key features not mentioned include Kayser-Fleischer rings and neurologic symptoms.

2. Hereditary hemochromatosis: Could explain the liver abnormalities and decreased circulating iron (due to excessive deposition in tissues). However, the copper and ceruloplasmin abnormalities do not fit this diagnosis.

3. Porphyria (e.g., acute intermittent porphyria): The abnormal porphyrin levels and childhood death suggest a possible porphyria. Some porphyrias can cause neuropsychiatric symptoms and liver dysfunction. However, the specific pattern of copper and iron abnormalities is not typical.  

4. Lysosomal storage disorder (e.g., Niemann-Pick disease type C): Can present with liver dysfunction, neurologic symptoms, and childhood death. The metabolic abnormalities could fit, but the specific copper and iron findings are not characteristic.

5. Mitochondrial disorder: The multisystem involvement (dental, hepatic, metabolic) and childhood death suggest a possible mitochondrial disorder. However, the specific pattern of copper, iron and porphyrin abnormalities is atypical and more suggestive of Wilson's disease.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause death in infancy/childhood if untreated. Other symptoms may include liver failure, renal dysfunction, and neurological problems.

2. Phenylketonuria (PKU): A disorder of phenylalanine metabolism leading to hyperphenylalaninemia. Untreated PKU can cause intellectual disability, seizures, and behavioral problems. Early death is possible without treatment.

3. Severe combined immunodeficiency (SCID): A group of disorders causing profound defects in cellular and humoral immunity. Presents with recurrent, severe infections and often leads to death in infancy without treatment. May be associated with metabolic abnormalities.

4. Galactosemia: A disorder of galactose metabolism that can present with death in infancy, liver disease, sepsis, and developmental delays if untreated. While not directly linked to the reported amino acid abnormalities, it should be considered in an infant with this presentation.

5. Biotinidase deficiency: A disorder of biotin metabolism that can cause hyperphenylalaninemia, seizures, hearing loss, and developmental delay. Symptoms may present in infancy and can be fatal if untreated. The lack of reported skin/hair findings makes this less likely but still possible.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Propionic acidemia: Consistent with aminoaciduria, elevated glycine, abnormal carnitine, and elevated urinary carboxylic acid. May also have ketoacidosis and hyperammonemia which were not reported.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia with aminoaciduria, elevated glycine, abnormal carnitine, and elevated urinary carboxylic acid. Megaloblastic anemia may also be present.

3. Non-ketotic hyperglycinemia: Marked by elevated glycine levels in plasma and CSF. Also causes seizures, hypotonia, and developmental delay which were not mentioned.

4. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: A disorder of fatty acid oxidation that can cause abnormal carnitine levels and elevated urinary dicarboxylic acids. Typically presents with hypoglycemia, vomiting and lethargy.

5. Carnitine transporter deficiency: Leads to very low plasma carnitine levels and can cause elevated urinary carboxylic acids. Symptoms include hypoglycemia, hepatomegaly, cardiomyopathy and muscle weakness.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Barth syndrome: Generalized hypotonia, 3-methylglutaconic aciduria, feeding difficulties, and risk of neonatal death are consistent with this rare X-linked mitochondrial disorder. Hepatomegaly and tachypnea can also occur. Neutropenia and cardiomyopathy are other key features not reported here.

2. Leigh syndrome: This mitochondrial disorder can present with hypotonia, tachypnea, feeding difficulties, and early death. 3-methylglutaconic aciduria has been reported in some cases. Hepatomegaly is less common. Other symptoms may include seizures, dystonia, and developmental regression.

3. Glutaric acidemia type 2: Generalized hypotonia, tachypnea, feeding problems, and risk of neonatal death fit with this organic acidemia. 3-methylglutaconic aciduria can be seen. Hepatomegaly is not typically a prominent feature. Characteristic odor and congenital anomalies are not mentioned here.

4. 3-methylglutaconic aciduria type 1: The elevated 3-methylglutaconic acid along with hypotonia, feeding issues, and early mortality match this disorder. Hepatomegaly and tachypnea are not classic features. Delayed development, seizures, and spasticity are often seen.

5. Congenital disorder of glycosylation type 1a: Feeding problems, hypotonia, hepatomegaly, and risk of early death are consistent. 3-methylglutaconic aciduria and tachypnea are not typically described. Other common features include abnormal fat pads, failure to thrive, and cerebellar hypoplasia.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Ornithine transcarbamylase (OTC) deficiency: Delayed development, hypoglycemia, hyperammonemia, respiratory alkalosis, and elevated plasma citrulline are consistent with this urea cycle disorder. Acute and chronic liver dysfunction can occur. Not typically associated with hyperhidrosis, pustules, or hypothermia.

2. Citrullinemia type I: Another urea cycle disorder that fits with the developmental delays, hyperammonemia, elevated citrulline, liver dysfunction, and potential for neonatal or childhood death. Additional symptoms like hypoglycemia and oroticaciduria can be seen.

3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Can present with hypoglycemia, lethargy, hepatic dysfunction, and risk of sudden death, especially in infancy or childhood. Developmental delays and hyperammonemia are less common features.  

4. Pyruvate dehydrogenase complex (PDHC) deficiency: Characterized by lactic acidosis, hypoglycemia, developmental delays, and potential liver abnormalities. Elevated citrulline and hyperammonemia would be less typical.

5. Glutaric aciduria type II: Can manifest with hypoglycemia, metabolic acidosis, liver enlargement and dysfunction, hypotonia, and risk of neonatal or infant death. Pustular skin lesions have been reported. Hyperammonemia, respiratory alkalosis, and elevated citrulline would be less common.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Macrocephaly, seizures, movement disorder, glutaric aciduria, and risk of death in infancy are all consistent. Typical symptoms not mentioned include developmental delay.

2. Canavan disease: Macrocephaly, seizures, hypotonia, and visual abnormalities fit, but glutaric aciduria would not be expected. Usually presents with leukodystrophy on MRI.

3. Mitochondrial disorder: Could explain neurological symptoms and risk of infant death. Glutaric aciduria is atypical. Additional symptoms may include other organ dysfunction, lactic acidosis.

4. Zellweger syndrome: Severe hypotonia, seizures, and early lethality fit, but macrocephaly is not typical, and visual abnormalities are more specific. Glutaric aciduria would be unusual.  

5. Early infantile epileptic encephalopathy: Explains seizures, irritability, hypotonia and risk of early death. Macrocephaly and movement disorder are less typical. Glutaric aciduria would not be expected.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Tyrosinemia type 1: Characterized by hypertyrosinemia, 4-hydroxyphenylpyruvic aciduria, and progressive liver disease leading to death in childhood if untreated. The patient's delayed development and elevated delta-aminolevulinic acid are also consistent.

2. Phenylketonuria (PKU): Causes elevated phenylalanine levels and can lead to delayed development and intellectual disability if untreated. However, the patient's other symptoms like liver dysfunction and porphyria are not typical of PKU.

3. Hereditary tyrosinemia type 2: Also leads to hypertyrosinemia but is generally less severe than type 1, so the patient's poor prognosis is less consistent with this diagnosis. Typical symptoms also include eye and skin lesions, which were not reported.

4. Acute intermittent porphyria (AIP): The elevated urinary delta-aminolevulinic acid raises suspicion for a porphyria. However, AIP typically presents with episodic abdominal pain, psychiatric symptoms, and neuropathy rather than developmental delays and liver disease.

5. Niemann-Pick disease type C: This lipid storage disorder can cause developmental delays, liver dysfunction, and childhood mortality similar to the patient's presentation. However, it is not typically associated with the reported amino acid and porphyrin abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, can present with developmental delay, intellectual disability, and early death if untreated. Missing symptom is unusual odor.

2. Tyrosinemia type I: Features hypertyrosinemia, elevated urinary carboxylic acid (succinylacetone), and high risk of early death from liver failure. Consistent with patient's presentation.

3. Maple syrup urine disease (MSUD): Causes elevated branched-chain amino acids and their ketoacids, leading to neonatal onset of poor feeding, lethargy, and death if untreated. Reported symptoms fit but would need to check for characteristic odor.

4. Glutaric acidemia type I: Involves elevated glutaric acid and risk of metabolic crisis in infancy/childhood. Matches reported carboxylic acid abnormality and early mortality.

5. 3-Methylcrotonyl-CoA carboxylase deficiency (3-MCC): Can present with elevated urinary 3-methylcrotonylglycine and risk of metabolic decompensation in infancy. Fits carboxylic acid finding but usually has better prognosis than patient.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, intellectual disability, seizures, and other neurological symptoms. The severe phenotype described could represent untreated classical PKU.

2. Tyrosinemia type II: Features hypertyrosinemia, intellectual disability, and short stature. The additional symptoms of seizures and early mortality suggest a particularly severe presentation. 

3. Mucopolysaccharidosis type III (Sanfilippo syndrome): A lysosomal storage disorder causing progressive neurodegeneration, hyperactivity, intellectual disability, seizures, and shortened lifespan. Coarse facial features and skeletal abnormalities may be present.

4. Niemann-Pick disease type C: Characterized by intellectual decline, seizures, and vertical gaze palsy. Visceral symptoms like hepatosplenomegaly are common. Prognosis is poor without treatment.

5. Mitochondrial disorder: The combination of neurological symptoms, growth failure, elevated metabolites, and multi-system involvement is consistent with a mitochondrial disorder, though the exact subtype would require further genetic and biochemical testing to elucidate. Many are associated with reduced life expectancy.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Characterized by metabolic acidosis, hyperammonemia, methylmalonic acidemia/aciduria, seizures, hypotonia, and early death if untreated. The patient's presentation is highly consistent with this diagnosis.

2. Propionic acidemia: Another organic acidemia that can present similarly to methylmalonic acidemia with metabolic acidosis, hyperammonemia, hypotonia, seizures, and risk of early death. Methylmalonic acid is not typically elevated.

3. Isovaleric acidemia: Can cause metabolic acidosis, hyperammonemia, vomiting, and neurological symptoms, but methylmalonic acid is not usually increased. Characteristic ""sweaty feet"" odor was not mentioned.

4. Urea cycle disorders (e.g., CPS1 deficiency, OTC deficiency): Lead to hyperammonemia, encephalopathy, seizures, and risk of neonatal death. However, metabolic acidosis and methylmalonic acidemia/aciduria would be atypical.

5. Multiple carboxylase deficiency (biotinidase deficiency, holocarboxylase synthetase deficiency): Can present with metabolic acidosis, hyperammonemia, seizures, hypotonia, and risk of early death if untreated. Methylmalonic aciduria can be seen, but the absence of other characteristic symptoms (e.g., skin rash, alopecia) makes this less likely.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Caused by methylmalonyl-CoA mutase deficiency, leading to methylmalonic aciduria, metabolic acidosis, hyperammonemia, vomiting, and risk of death in infancy if untreated. May also have ketoacidosis, neutropenia, and pancytopenia which were not reported here.

2. Propionic acidemia: Another organic acidemia caused by propionyl-CoA carboxylase deficiency. Also presents with metabolic acidosis, hyperammonemia, vomiting in infancy. Would expect propionic aciduria rather than methylmalonic aciduria.

3. Holocarboxylase synthetase deficiency: Leads to multiple carboxylase deficiency, including methylmalonyl-CoA mutase. Presents similarly in infancy with metabolic acidosis, hyperammonemia, vomiting, and risk of death. Urine organic acids would show methylmalonic aciduria plus other abnormalities.  

4. Cobalamin defects (e.g. cblA, cblB, cblC, cblD): Disrupt synthesis of adenosylcobalamin, a cofactor for methylmalonyl-CoA mutase, leading to methylmalonic aciduria. Present similarly to isolated methylmalonic acidemia. Megaloblastic anemia may be present but was not reported.

5. Transient maternal B12 deficiency: Inadequate B12 transfer to the fetus can cause methylmalonic aciduria and symptoms that mimic an inborn error of metabolism. Maternal B12 levels and response to B12 supplementation help distinguish this.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's hyperammonemia, seizures, cerebral edema, and orotic aciduria. X-linked recessive inheritance may explain neonatal death in males. Respiratory alkalosis is another key feature not reported.

2. Citrullinemia type I (argininosuccinate synthetase deficiency): Also matches hyperammonemia, neurological symptoms, and neonatal presentation. Citrulline would be very elevated on plasma amino acids.

3. Argininosuccinic aciduria (argininosuccinate lyase deficiency): Similar presentation to citrullinemia. Argininosuccinic acid would be elevated in urine.

4. Carbamoyl phosphate synthetase I deficiency: Neonatal hyperammonemia, seizures, and death all fit. This disorder would have low citrulline in contrast to the other urea cycle defects.

5. Transient hyperammonemia of the newborn: If a urea cycle defect is not identified, this is a possibility in a neonate with severe hyperammonemia. However, the lack of spontaneous resolution and neonatal death make a genetic cause much more likely.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Glutaric aciduria type 1: Consistent with seizures, hypotonia, developmental delay, and elevated urinary carboxylic acid. Additional symptoms can include macrocephaly and dystonia.

2. Menkes disease: Matches symptoms of seizures, hypotonia, growth delay, death in infancy. Caused by copper transport defects. Other features include sparse, brittle hair and skin laxity.

3. Mitochondrial disorder: Can explain multisystem involvement with neurologic symptoms, growth delay, and elevated metabolites. Further subtype classification would require genetic testing.

4. Zellweger syndrome (a peroxisomal disorder): Fits with hypotonia, seizures, growth delay, and early death. May also have distinctive facial features and liver dysfunction.

5. Spinal muscular atrophy type 1: A motor neuron disease characterized by hypotonia, developmental delay, fasciculations, and early death. Would not expect metabolic abnormalities or alopecia.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, can also cause hypercholesterolemia and lead to liver failure and early death if untreated. Other features like liver dysfunction and renal tubular acidosis were not mentioned.

2. Phenylketonuria (PKU): The elevated phenylalanine is consistent with PKU. Classically causes intellectual disability, but some variants are associated with obesity and premature cardiovascular disease. Tyrosine is usually low in untreated PKU.

3. Niemann-Pick disease type B: This lysosomal acid sphingomyelinase deficiency causes accumulation of sphingomyelin and cholesterol in lysosomes. Leads to hepatosplenomegaly, hypercholesterolemia, and often early mortality. The amino acid abnormalities would be atypical.

4. Alkaptonuria: A defect in tyrosine degradation that causes hypertyrosinemia and buildup of homogentisic acid. Features include dark urine, early arthritis, and heart valve disease. Phenylalanine is not usually elevated and life expectancy is often normal.

5. Heterozygous familial hypercholesterolemia (FH): Characterized by elevated LDL cholesterol and premature cardiovascular disease. Obesity is common. FH alone would not explain the amino acid findings or very early mortality.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Smith-Lemli-Opitz syndrome: Characterized by hypospadias, growth deficiency, feeding difficulties, and failure to thrive in infancy. Can be life-threatening. Caused by an inborn error of cholesterol synthesis.

2. Zellweger spectrum disorders: Group of rare metabolic disorders causing severe symptoms in infancy, including feeding problems, hypotonia, seizures, and liver dysfunction. Can lead to premature birth and neonatal death.

3. Trisomy 18 (Edwards syndrome): Chromosomal disorder associated with low birth weight, heart and kidney malformations, hypospadias in males, hernia, severe developmental delays, and high infant mortality.

4. Cornelia de Lange syndrome: Rare genetic disorder characterized by distinctive facial features, short stature, limb abnormalities, hypospadias, hernia, severe developmental delays, and failure to thrive. Can be associated with premature birth.

5. Beckwith-Wiedemann syndrome: Overgrowth syndrome associated with macrosomia, hypoglycemia, abdominal wall defects, and increased risk of certain childhood cancers. Can cause premature birth and rarely neonatal death, but not consistent with this patient's short stature.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Characterized by intellectual disability, microcephaly, syndactyly, growth deficiency, and elevated 7-dehydrocholesterol due to a defect in 7-dehydrocholesterol reductase. Consistent with the patient's craniofacial, skeletal, developmental, and biochemical features.

2. Antley-Bixler syndrome: Features include craniofacial abnormalities, radiohumeral synostosis, femoral bowing, and impaired steroidogenesis. Some overlap with the patient's presentation, but 7-dehydrocholesterol is not typically elevated.

3. Greenberg dysplasia: Rare disorder of cholesterol biosynthesis causing skeletal abnormalities, hydrops fetalis, and early lethality. Shares some features with the patient but lacks the characteristic craniofacial and developmental findings.

4. Trisomy 13: Multiple congenital anomalies including microcephaly, cleft lip/palate, congenital heart defects, intellectual disability, and early death. Some overlap with the patient's features, but lacks the specific cholesterol abnormalities.

5. Cornelia de Lange syndrome: Characterized by distinctive facial features, growth deficiency, intellectual disability, and limb defects. Shares some of the patient's craniofacial and developmental symptoms but does not typically involve abnormal sterol metabolism.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: The patient's neurological symptoms, glutaric aciduria, elevated glutaric acid, abnormal acylcarnitine profile, and decreased plasma carnitine are all consistent with this inborn error of lysine and tryptophan metabolism. Decompensation during acute illness is characteristic.

2. Leigh syndrome (subacute necrotizing encephalomyelopathy): Progressive neurological deterioration, ataxia, and death in childhood can be seen with this mitochondrial disorder. However, the specific biochemical findings are more suggestive of glutaric acidemia.

3. Propionic acidemia: Another organic acidemia that can present with neurological symptoms, metabolic decompensation, and hyperammonemia. The patient's glutaric aciduria points away from this diagnosis.

4. Infantile neuroaxonal dystrophy: Ataxia, athetosis, and progressive neurological deterioration are consistent, but this is a rare disorder and would not cause the metabolic abnormalities seen.

5. Molybdenum cofactor deficiency: Can cause intractable seizures, opisthotonus, and death in early infancy. Absence of seizures and presence of glutaric aciduria make this diagnosis less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Autosomal recessive disorder causing hypertyrosinemia, failure to thrive, liver dysfunction, and risk of early death. Consistent with patient's hypertyrosinemia, abnormal development, hypotonia, and infant/neonatal death.

2. Phenylketonuria (PKU): Autosomal recessive disorder of phenylalanine metabolism causing hyperphenylalaninemia, intellectual disability, seizures, and musculoskeletal abnormalities if untreated. Matches patient's hyperphenylalaninemia, motor delay, hypotonia, and hip dysplasia. No report of fair complexion, eczema, or intellectual disability.

3. Peroxisomal biogenesis disorders (e.g. Zellweger syndrome): Autosomal recessive disorders impairing peroxisome function, causing abnormal development, hypotonia, skeletal abnormalities, and early death. Aligns with patient's presentation, but no report of hearing/vision impairment, seizures, or liver dysfunction.

4. Maple syrup urine disease: Autosomal recessive branched-chain amino acid disorder, causing poor feeding, lethargy, hypotonia, intellectual disability, and risk of metabolic decompensation and death. Some overlap with patient's symptoms, but no report of maple syrup odor to urine or episodic decompensation.

5. Smith-Lemli-Opitz syndrome: Autosomal recessive cholesterol synthesis disorder causing intellectual disability, hypotonia, failure to thrive, and multiple congenital anomalies. Matches some of patient's features, but no mention of characteristic facial features, cleft palate, heart defects, or genital abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Elevated tyrosine, neurological issues, risk of early death; other features can include liver failure and renal dysfunction

2. Phenylketonuria (PKU): Hyperphenylalaninemia, intellectual disability, seizures; patient's lack of reported ""musty"" odor is atypical 

3. Zellweger spectrum disorder: Hypotonia, seizures, abnormal facial features, and early death are consistent; absence of liver dysfunction is unusual

4. Maple syrup urine disease: Presents with poor feeding, hypotonia, seizures, and risk of neonatal death; the lack of reported urine odor is inconsistent

5. Nonketotic hyperglycinemia: Hypotonia, seizures, apnea, and early death fit; opisthotonus can occur but is not a classic feature",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Phenylketonuria (PKU): Characterized by intellectual disability, seizures, motor delay, and hyperphenylalaninemia. Other features can include autism, hyperactivity, and self-injurious behavior. The patient's elevated phenylalanine level is a key finding.

2. Tyrosinemia type I: Features acute liver failure, renal dysfunction, and neurological problems including intellectual disability, self-mutilation, and hyperactivity. The patient's hypertyrosinemia fits, but additional findings of liver disease and renal tubular dysfunction are not reported.

3. Lesch-Nyhan syndrome: An X-linked disorder of purine metabolism causing intellectual disability, self-mutilating behavior, motor delay, and hyperuricemia. Seizures and early death can occur. The patient's self-injury is characteristic, but uric acid levels are not mentioned.

4. Mucopolysaccharidosis type III (Sanfilippo syndrome): A lysosomal storage disorder with progressive neurodegeneration, causing intellectual decline, autistic behaviors, hyperactivity, and seizures. Early mortality is common. Lacking are coarse facial features and hepatomegaly typical of this condition.

5. Maple syrup urine disease: A disorder of branched-chain amino acid metabolism, presenting with poor feeding, vomiting, lethargy, intellectual disability, seizures, and a maple syrup odor to the urine. Can be life-threatening in infancy. The patient's elevated alanine could fit, but additional features of metabolic decompensation are not described.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Consistent with hypergalactosemia, vomiting, increased bilirubin, and risk of neonatal death if untreated. Key symptom not reported is cataracts.

2. Hereditary fructose intolerance: Can cause vomiting, liver dysfunction leading to hyperbilirubinemia, and risk of death in infancy. However, does not typically cause hypergalactosemia.

3. Tyrosinemia type 1: Causes liver failure, vomiting, and increased risk of infant death. Increased bilirubin would be expected, but not hypergalactosemia specifically. 

4. Niemann-Pick disease type A: Can present with vomiting, liver dysfunction, and early infant death. Hypergalactosemia is not a typical finding.

5. Zellweger syndrome: A peroxisomal disorder that can cause vomiting, liver dysfunction, and neonatal death. Hypergalactosemia is not commonly reported.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU), severe form: Characterized by hyperphenylalaninemia and can cause intellectual disability, seizures, and death if untreated. Abnormality of prenatal development and neonatal death are consistent.

2. Tyrosinemia type I: Causes abnormal tyrosine levels and can lead to liver failure, kidney dysfunction, and neurological problems. Neonatal death is characteristic of the severe acute form.

3. Maple syrup urine disease (MSUD): Disrupts metabolism of branched-chain amino acids, causing a toxic buildup that leads to poor feeding, lethargy, seizures, coma and death in untreated neonates. Patient's symptoms fit but elevated branched-chain amino acids not specifically mentioned.

4. Nonketotic hyperglycinemia (NKH): Impairs glycine breakdown, causing lethargy, hypotonia, seizures and apnea in neonates. Can be rapidly progressive and fatal. Glycine levels not reported for this patient.

5. Multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS): Rare condition causing prenatal developmental abnormalities, hypotonia, seizures and intellectual disability. Can be fatal in neonatal period but specific amino acid abnormalities not usually seen.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Characterized by obesity, carnitine deficiency, and high risk of early death due to cardiac or liver failure, especially triggered by fasting or illness. Key symptoms not reported include hypoglycemia, cardiomyopathy, and muscle weakness.

2. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Causes impaired ability to break down medium-chain fats, leading to symptoms during fasting or stress. Consistent with reported early mortality risk, but obesity is less common. Additional symptoms may include vomiting, lethargy, seizures, and coma.

3. Carnitine palmitoyltransferase II (CPT II) deficiency: Leads to reduced ability to transport long-chain fatty acids for energy production. Matches reported carnitine abnormality and increased mortality risk. Other symptoms often include recurrent muscle pain and weakness, especially with exercise.

4. Glycogen storage disease type Ia (von Gierke disease): A glycogen storage disorder causing hypoglycemia, growth retardation, and early mortality risk. Consistent with reported childhood deaths, but obesity and carnitine abnormalities are less typical. Additional symptoms usually include enlarged liver, kidney dysfunction, and uric acid buildup.

5. Congenital generalized lipodystrophy: A rare condition of near total body fat loss, insulin resistance, and metabolic abnormalities. Matches reported altered fat metabolism and early mortality, but is inconsistent with obesity. Patients often have a distinct muscular appearance, enlarged liver, high blood sugar, and high triglycerides.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, intellectual disability, and high mortality in untreated patients. Other features can include liver dysfunction, renal tubular dysfunction, and neurological crises.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Neonatal screening and early treatment can prevent severe symptoms. Patient's hypertyrosinemia and reported deaths would be atypical.

3. Tyrosinemia type II: Presents with hypertyrosinemia and intellectual disability, but is generally less severe than type I. Lacks the liver and kidney dysfunction and high mortality risk seen in this patient.

4. Hawkinsinuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. Intellectual disability is not a typical feature.

5. Transient tyrosinemia of the newborn: A benign condition causing temporarily elevated tyrosine levels in neonates. Intellectual disability and early death would not be expected.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Characterized by the patient's multiple congenital anomalies, intellectual disability, failure to thrive, and elevated 7-dehydrocholesterol. The patient's neurological, eye, and skin findings are consistent. Severe cases can result in infant death.

2. Inborn error of metabolism (other than Smith-Lemli-Opitz): The patient's neurological symptoms, failure to thrive, skin findings, and metabolic abnormalities suggest a possible metabolic disorder, though the elevated 7-dehydrocholesterol points specifically to Smith-Lemli-Opitz. Further metabolic testing could evaluate for other disorders.

3. Chromosomal disorder (e.g. trisomy): Patient's multiple congenital anomalies, intellectual disability, and neurological findings could fit with a chromosomal abnormality. Would expect other structural birth defects. Karyotype or microarray could evaluate for this.

4. Congenital infection (e.g. CMV, toxoplasmosis): Microcephaly, intellectual disability, hearing loss, eye findings, and rash could be explained by a congenital infection. However, this would not account for the elevated 7-dehydrocholesterol.

5. Primary immunodeficiency: The patient's recurrent viral infections suggest immune dysfunction. However, a primary immunodeficiency would not typically cause multiple congenital anomalies, intellectual disability, or elevated 7-dehydrocholesterol.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Rare genetic disorder causing progressive damage to nerve cells in the brain. Consistent with patient's hypotonia, cerebral atrophy, and death in infancy. Characterized by elevated N-acetylaspartic acid levels.

2. Maple syrup urine disease: Inherited disorder of amino acid metabolism leading to buildup of branched-chain amino acids and ketoacids. Matches patient's neurological symptoms, fever, and abnormal amino acids. Additional symptoms may include feeding problems, urine odor.

3. Phenylketonuria (PKU): Genetic disorder causing buildup of phenylalanine. Untreated PKU results in intellectual disability, seizures, and behavioral problems. Consistent with developmental delay and neurological issues. Screening should show elevated phenylalanine levels.

4. Niemann-Pick disease type C: Rare progressive genetic disorder causing accumulation of cholesterol and glycosphingolipids in lysosomes. Leads to neurological deterioration, eye movement abnormalities, and systemic symptoms. Matches strabismus, hypotonia, developmental delay. May have hepatosplenomegaly.

5. Leigh syndrome: Rare neurometabolic disorder causing progressive brain damage. Caused by mutations in mitochondrial DNA or nuclear DNA. Consistent with patient's neurological symptoms, cerebral atrophy, and early mortality. Other features may include respiratory abnormalities, heart problems.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Inborn error of metabolism (e.g., phenylketonuria, tyrosinemia): The patient has hyperphenylalaninemia and hypertyrosinemia, which are seen in metabolic disorders. These conditions can lead to intellectual disability, liver problems, and early death if untreated.

2. Congenital heart disease: The patient has coarctation of the aorta, a congenital heart defect that can cause heart failure and death if severe and not repaired. This could explain the deaths in infancy and childhood.

3. Chromosomal disorder (e.g., Edwards syndrome, Patau syndrome): Chromosomal abnormalities can cause a constellation of birth defects, including heart malformations, intellectual disability, and other congenital anomalies. Many are associated with shortened lifespan.

4. Prader-Willi syndrome: This genetic disorder is characterized by obesity, intellectual disability, and respiratory problems. While not usually fatal in infancy or childhood, it can lead to life-threatening complications.

5. Congenital infection (e.g., congenital CMV, toxoplasmosis): Certain infections during pregnancy can cause birth defects, including heart defects, vision and hearing problems, and intellectual disability. Severe cases may result in stillbirth or neonatal death. However, later childhood deaths would be less likely.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Classical homocystinuria: Characterized by elevated homocysteine and methionine, developmental delay, and early mortality if untreated. Fits with hyperhomocystinemia, hypermethioninemia, and aminoaciduria.

2. Methionine adenosyltransferase deficiency: Features hypermethioninemia, abnormal development, and neonatal/early death in severe cases. Matches hypermethioninemia and early death.

3. Methylenetetrahydrofolate reductase (MTHFR) deficiency: Can present with hyperhomocystinemia, developmental abnormalities, and early childhood death. Aligns with hyperhomocystinemia and mortality.

4. Propionic acidemia: An organic acidemia with high mortality, intellectual disability, and abnormal development. Could explain infant/childhood death and abnormal development, but key symptoms of lactic acidosis and hyperammonemia are lacking.

5. Argininosuccinic aciduria: A urea cycle defect causing hyperammonemia, developmental delay, and high mortality. Matches abnormal development and early death, but the patient's amino acid abnormalities are not typical of this condition.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: Autosomal recessive disorder causing deficient breakdown of pyrimidines. Consistent with patient's ataxia, hypotonia, elevated pyrimidines and uracil, and potential for early death. Seizures and intellectual disability also common but not reported here.

2. Dihydropyrimidinase deficiency: Autosomal recessive condition with deficient second step of pyrimidine degradation. Matches patient's ataxia, hypotonia, uraciluria, and elevated pyrimidines. However, this is usually less severe than dihydropyrimidine dehydrogenase deficiency.

3. Beta-ureidopropionase deficiency: Rare autosomal recessive disorder of pyrimidine metabolism. Fits with ataxia, hypotonia, abnormal pyrimidine levels and uraciluria. Additional features can include seizures, intellectual disability, and autistic behaviors.

4. Mitochondrial DNA depletion syndrome: Group of autosomal recessive disorders causing progressive multi-organ dysfunction. Some forms involve the brain and liver, consistent with neurological symptoms and metabolic abnormalities. However, specific pyrimidine defects are not typical.

5. Inborn error of pyrimidine synthesis (e.g. orotic aciduria): Disorders of pyrimidine synthesis are less likely here, as they typically cause blood cell abnormalities due to impaired DNA/RNA production. Neurological symptoms can occur but are not primary features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver and kidney dysfunction, neurological problems, and risk of early death if untreated. Hyperphenylalaninemia is not typically seen.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and severe intellectual disability if untreated, but not usually hypertyrosinemia. Death in early adulthood would be atypical.

3. Alkaptonuria: Features hypertyrosinemia but not hyperphenylalaninemia. Leads to arthritis and heart valve problems but normal lifespan. 

4. Hawkinsinuria: Rare disorder with hypertyrosinemia and metabolic acidosis. Limited information on long-term outcomes.

5. Transient tyrosinemia of the newborn: Common benign condition with temporary elevations of tyrosine. Resolves on its own and does not cause other health problems.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase (DPD) deficiency: Consistent with death in infancy, neonatal death, respiratory insufficiency, abnormal pyrimidine levels, and uraciluria. The hallmark biochemical finding is the patient's uraciluria.

2. Uridine monophosphate synthase (UMPS) deficiency: Another pyrimidine disorder that can present with respiratory insufficiency and early death. However, orotic aciduria would be expected rather than uraciluria.

3. Zellweger spectrum disorder: A peroxisomal biogenesis disorder that can cause infantile death, respiratory compromise, and metabolic abnormalities. Additional symptoms like hypotonia, seizures, and liver dysfunction are not reported.

4. Spinal muscular atrophy (SMA) type 0: A severe motor neuron disorder that causes respiratory failure and death in early infancy. Does not fully explain the pyrimidine abnormalities.

5. Surfactant metabolism dysfunction, pulmonary, type 1: A rare lung disorder causing respiratory failure in term infants. Uraciluria would not be expected.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Tyrosinemia type 1: Characterized by liver dysfunction, renal tubular dysfunction, and neurologic symptoms. Consistent with patient's hypertyrosinemia, liver abnormalities, ascites, anemia, and aminoaciduria.

2. Erythropoietic protoporphyria: Can present with photosensitivity, liver disease, and gallstones. Matches patient's abnormal porphyrin levels and liver dysfunction. Additional symptoms may include rash and red urine.

3. Biliary atresia: Causes neonatal obstructive jaundice and progressive liver damage. Explains elevated liver enzymes, ascites, hypoalbuminemia, and coagulopathy. Pale stools and dark urine would support this diagnosis.

4. Neonatal hemochromatosis: Leads to liver failure and can cause anemia, thrombocytopenia, hypoglycemia, and ascites as seen in this patient. Ferritin levels and liver biopsy would help diagnose.

5. Niemann-Pick disease type C: Lysosomal storage disorder causing hepatosplenomegaly, developmental delay, and neurologic symptoms. Could explain liver abnormalities and ascites. May have cherry-red spot on eye exam.",Hereditary metabolic disorders
['Canavan disease'],"1. Argininosuccinic aciduria: Matches the patient's seizures, developmental delay, early mortality, and abnormal aspartate levels. May also present with hyperammonemia, liver dysfunction, and brittle hair (not reported).

2. Citrullinemia type I: Consistent with seizures, motor delay, death in infancy, and elevated aspartate. Additional features may include lethargy, poor feeding, and coma (not mentioned).

3. Canavan disease: Explains motor delay and early death. Caused by aspartoacylase deficiency leading to high aspartate levels. Other findings can include macrocephaly, optic atrophy, and leukodystrophy on brain MRI (not reported).

4. Pyruvate dehydrogenase complex deficiency: Can present with seizures, developmental delay, and early death. Lactate and alanine levels may also be elevated (unknown for this patient). Aspartate is not typically a primary biomarker.

5. Molybdenum cofactor deficiency: Matches seizures, motor delay, and early mortality. Characterized by low uric acid and elevated sulfite, xanthine, and hypoxanthine (aspartate not a classic finding). Can also have dysmorphic facial features and dislocated ocular lenses (not noted).",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Symptoms consistent with this diagnosis include vomiting, lethargy, failure to thrive in infancy, and high mortality. Key features not reported include hypoglycemia, hyperammonemia, and acidosis.

2. Methylmalonic acidemia: Similar to propionic acidemia, this disorder can cause vomiting, failure to thrive, lethargy, metabolic decompensation, and early death. Additional findings may include metabolic acidosis, ketosis, and hyperammonemia.  

3. Severe combined immunodeficiency (SCID): The recurrent viral infections and early mortality fit with a diagnosis of SCID. However, the gastrointestinal symptoms and metabolic abnormalities are less typical of SCID.

4. Glutaric acidemia type 1: This metabolic disorder is characterized by macrocephaly, dystonia, and degeneration of the basal ganglia, usually triggered by an infection in infancy or early childhood. While the patient's infections and early deaths could fit, other cardinal symptoms were not described.

5. Urea cycle disorders (e.g. ornithine transcarbamylase deficiency): These conditions often present in the neonatal period with poor feeding, vomiting, lethargy progressing to coma, and death without prompt treatment. Hallmarks include hyperammonemia, respiratory alkalosis, and low BUN.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type II: Characterized by hypertyrosinemia, intellectual disability, and elevated urinary carboxylic acids. However, this condition is not typically associated with hyperphenylalaninemia or early mortality.

2. Phenylketonuria (PKU): Features hyperphenylalaninemia and intellectual disability if untreated. However, PKU does not cause hypertyrosinemia, carboxylic aciduria, or death in adolescence/early adulthood when treated.

3. Hawkinsinuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. However, it is not associated with hyperphenylalaninemia, intellectual disability, or early mortality.

4. Glutaric aciduria type I: An organic aciduria presenting with elevated urinary carboxylic acids, metabolic acidosis, and neurological deterioration, often leading to early mortality. However, amino acid abnormalities are not typical.

5. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency: A severe organic aciduria characterized by hypoketotic hypoglycemia, metabolic acidosis, elevated urinary carboxylic acids, intellectual disability, and early mortality. Amino acid abnormalities can occur secondarily. This condition most closely fits the patient's overall presentation.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Pyruvate dehydrogenase complex deficiency: Consistent with hyperalaninemia, abnormal carnitine, neonatal/childhood death. May also have lactic acidosis and neurological abnormalities.

2. Propionic acidemia: Features hyperalaninemia, abnormal carnitine, poor growth, and risk of early death. Severe cases can have hearing loss. Lactic acidosis and hyperammonemia may be present.  

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with hyperalaninemia, abnormal carnitine, growth restriction, and early mortality risk. Can also involve hearing loss.

4. GRACILE syndrome: Rare condition featuring growth restriction, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death. Hearing impairment can occur.

5. Zellweger spectrum disorder: Includes prenatal growth restriction, metabolic abnormalities, and risk of infant death. Often involves liver dysfunction, vision/hearing impairment, and bone abnormalities. Lactic acidosis may be seen.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's oroticaciduria, hyperammonemia, lethargy, and potential for infant death if severe. A key feature not mentioned is protein intolerance/avoidance.

2. Citrullinemia type I: Explains the lethargy, drowsiness, sleep disturbance, and hyperammonemia. Additional symptoms may include vomiting, seizures, and coma.

3. Argininosuccinic aciduria: Accounts for the neurological symptoms, oroticaciduria, and hyperammonemia. Other signs not reported include intellectual disability, seizures, and brittle hair.

4. Carbamoyl phosphate synthetase I deficiency: Matches the severe lethargy and risk of neonatal death. Protein aversion and respiratory alkalosis are additional features.

5. Hyperammonemia-hyperornithinemia-homocitrullinuria (HHH) syndrome: Explains the elevated ornithine, lethargy, and drowsiness. Patients may also have intellectual disability, seizures, and spasticity, which were not noted.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Glutaric aciduria, ataxia, dystonia, abnormal cerebral morphology, abnormal myelination, and death in childhood are all consistent with this diagnosis. Decreased plasma carnitine is sometimes seen as well.

2. Propionic acidemia: Can present with metabolic acidosis, neurological symptoms, abnormal brain development, and risk of childhood death similar to this patient. However, glutaric aciduria is not typically seen.

3. Methylmalonic acidemia: Another organic acidemia that shares features with propionic acidemia and could explain many of the patient's symptoms. Glutaric aciduria would be unusual though.

4. Primary carnitine deficiency: The decreased plasma free carnitine raises this possibility. It can cause neurological symptoms and metabolic crises, but the degree of cerebral abnormalities and childhood mortality risk may be less severe than this patient's presentation.

5. Multiple acyl-CoA dehydrogenase deficiency (MADD): A fatty acid oxidation disorder that can lead to low carnitine, metabolic acidosis, neurological impairment, and risk of childhood death. The specific finding of glutaric aciduria would be atypical but has been reported in rare cases.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia and can lead to severe intellectual disability, seizures, and death if untreated in infancy. Consistent with this patient's hyperphenylalaninemia and neonatal death.

2. Defects in biopterin metabolism (e.g. dihydropteridine reductase deficiency): Can cause hyperphenylalaninemia and neurologic deterioration in infancy. May fit with hyperphenylalaninemia and neonatal death in this case.

3. Tyrosinemia type I: Another disorder of amino acid metabolism that can present with failure to thrive and death in infancy if untreated. Usually also have liver dysfunction and renal tubular dysfunction. Patient's hyperphenylalaninemia could be secondary to liver disease.

4. Maple syrup urine disease: Disorder of branched-chain amino acid metabolism presenting in the neonatal period with poor feeding, lethargy, and death if untreated. Urine has characteristic sweet odor. Hyperphenylalaninemia not typically seen.

5. Urea cycle disorders (e.g. ornithine transcarbamylase deficiency): Cause hyperammonemia and encephalopathy, often progressing rapidly in the neonatal period. Can be fatal if not promptly treated. Hyperphenylalaninemia is not a primary feature.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"1. Propionic acidemia: Symptoms consistent with this diagnosis include encephalopathy, cardiomyopathy, hypotonia, anemia, hypoglycemia, hepatomegaly, and elevated transaminases. Key features like abnormal alanine and other circulating amino acids and decreased plasma carnitine also fit. Vomiting is common during acute decompensation episodes.

2. Methylmalonic acidemia: Many of the patient's symptoms overlap with propionic acidemia and can be seen in methylmalonic acidemia, including encephalopathy, hypotonia, metabolic abnormalities, and decreased carnitine. Methylmalonic acid levels would be elevated.

3. Fatty acid oxidation disorders (e.g., MCAD deficiency, VLCAD deficiency): These disorders can present with hypoglycemia, encephalopathy, cardiomyopathy, hepatomegaly, and elevated transaminases. Decreased plasma carnitine is a key finding. Specific acylcarnitine elevations on newborn screening can point to the specific enzyme deficiency.

4. Urea cycle disorders: The patient's irritability, encephalopathy, coma, hypotonia, vomiting, and elevated transaminases could fit with a urea cycle disorder. Hyperammonemia is a key finding that was not reported here but would be expected. Abnormal amino acid levels can help distinguish the specific enzyme deficiency.

5. Mitochondrial disorders: The multisystem involvement, including brain, heart and liver, could be consistent with a mitochondrial disorder. Features like hypotonia, encephalopathy, hypoglycemia, and elevated transaminases fit. Lactic acidosis and abnormal mitochondrial morphology on muscle biopsy would support this diagnosis.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by cerebellar vermis hypoplasia, hypotonia, ataxia, abnormal eye movements, and developmental delays. Matches the patient's cerebellar dysfunction, eye findings, hypotonia, and delays. 

2. Pontocerebellar hypoplasia (PCH): A group of autosomal recessive disorders causing degeneration of the cerebellum and pons. Consistent with the patient's cerebellar atrophy/agenesis, generalized hypotonia, developmental delays, and poor prognosis.

3. Walker-Warburg syndrome: A congenital muscular dystrophy with brain and eye abnormalities. Fits with the patient's hypotonia, eye findings (possible retinal abnormalities), cerebellar malformation, developmental delays, and high infantile mortality.

4. Congenital disorder of glycosylation (CDG): A group of inherited metabolic disorders causing severe neurological dysfunction. Matches the patient's cerebellar atrophy, hypotonia, ataxia, strabismus, psychomotor retardation, and failure to thrive. Additional symptoms may include seizures and distinctive facial features.

5. Zellweger spectrum disorder: A peroxisomal biogenesis disorder characterized by craniofacial dysmorphism, neurological dysfunction, and multi-organ involvement. Consistent with the patient's hypotonia, nystagmus, psychomotor delays, and early mortality. May also have hearing and vision impairment, seizures, and liver dysfunction.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria: Characterized by myopia, ectopia lentis, intellectual disability, delayed development, and elevated homocysteine. Can cause early mortality if untreated. Patient has all key features.

2. Sulfite oxidase deficiency: Causes intellectual disability, ectopia lentis, and early death. Elevated sulfur-containing amino acids like homocysteine and methionine. Lacks typical neurologic symptoms like seizures and movement disorders.

3. Molybdenum cofactor deficiency: Can present with myopia, ectopia lentis, intellectual disability, and early death. Usually also has intractable seizures, which this patient lacks.

4. Marfan syndrome: Features myopia, ectopia lentis, and intellectual disability. Does not typically cause metabolic abnormalities like aminoaciduria and elevated homocysteine/methionine.

5. Hyperlysinemia: An aminoacidopathy that can cause intellectual disability, myopia, and aminoaciduria. Does not usually involve ectopia lentis or elevated homocysteine/methionine.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Hyperammonemia, seizures, lethargy, metabolic acidosis, and death in childhood/adolescence are consistent. Oroticaciduria is a key finding. Fever and diarrhea are not typical.

2. Propionic acidemia: Metabolic acidosis, hyperammonemia, lethargy, seizures, and death in childhood fit. Ataxia and hyperreflexia can occur. Oroticaciduria would be unusual.

3. Methylmalonic acidemia: Presents similarly to propionic acidemia with metabolic acidosis, hyperammonemia, lethargy, seizures, and death in childhood. Oroticaciduria is not expected.

4. Urea cycle disorders (other than OTC deficiency): Hyperammonemia, seizures, lethargy, and death in childhood/adolescence fit. Specific disorders like citrullinemia or argininosuccinic aciduria are possible. Ataxia, hyperreflexia, and oroticaciduria are less common.  

5. Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS): Seizures, ataxia, lethargy, and metabolic acidosis fit. Fever and diarrhea could occur. Hyperammonemia and oroticaciduria would be unusual. Stroke-like episodes and lactic acidosis are not reported.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Characterized by intellectual disability, microcephaly, ptosis, syndactyly, failure to thrive, and elevated 7-dehydrocholesterol levels, all of which are seen in this patient. Other features like cleft palate, hypospadias, and congenital heart defects were not mentioned.

2. Trisomy 18 (Edwards syndrome): Some overlapping features including intellectual disability, microcephaly, short chin, failure to thrive, and risk of early death. However, trisomy 18 is not typically associated with the specific biochemical abnormalities seen here.

3. Zellweger spectrum disorders: Group of peroxisomal biogenesis disorders that can cause intellectual disability, hypotonia, failure to thrive, and distinct facial features. Usually also associated with seizures, liver dysfunction, and vision/hearing impairment, which were not reported.

4. Congenital disorders of glycosylation: Rare group of metabolic disorders that can present with developmental delay, hypotonia, failure to thrive, and various congenital anomalies. Specific patterns may be seen on transferrin testing.

5. Chromosomal microdeletion or microduplication syndrome: Some genetic syndromes like 1p36 deletion or 22q11.2 deletion can cause intellectual disability, craniofacial abnormalities, and other congenital anomalies. Microarray testing would be needed to identify such a condition.",Hereditary metabolic disorders
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"1. Pyruvate dehydrogenase complex deficiency: Consistent with lactic acidosis, hypotonia, and early death. May also have seizures and brain abnormalities not reported here.

2. Mitochondrial DNA depletion syndrome: Matches the multisystem involvement, lactic acidosis, liver dysfunction, and poor prognosis. Specific type would depend on genetic testing.

3. Propionic acidemia: Can explain hypotonia, metabolic acidosis, hyperammonemia, and early death. Characteristic urine organic acid profile would support this diagnosis.

4. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Presents with hypoglycemia, hepatomegaly, and increased risk for sudden death. Lacks the lactic acidosis seen in this patient.

5. Carnitine palmitoyltransferase II (CPT II) deficiency: Associated with hypoketotic hypoglycemia, liver dysfunction, and rhabdomyolysis. Muscle weakness is usually more episodic than the generalized hypotonia described here.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Characterized by macrocephaly, progressive dystonia and athetosis, hypotonia, glutaric aciduria, and characteristic brain atrophy/lesions. Fits well with this patient's presentation.

2. Pyruvate dehydrogenase deficiency: Can present with microcephaly, hypotonia, lactic acidosis, and early death. Brain abnormalities and athetosis can occur. Elevated pyruvate and lactate levels would support this.

3. Propionic acidemia: Features can include hypotonia, movement disorders, metabolic acidosis, hyperammonemia, and early death. Microcephaly and brain atrophy are less common. Propionyl carnitine would be elevated.

4. Molybdenum cofactor deficiency: Causes microcephaly, neonatal seizures, and early death. Hypotonia and brain changes can be seen. Sulfite oxidase deficiency may co-occur. Urine sulfite and xanthine levels would be high.

5. Zellweger syndrome (a peroxisomal biogenesis disorder): Classic signs include profound hypotonia, distinctive facies, seizures, and early death. Microcephaly and brain abnormalities are typical. Elevated very long chain fatty acids would be expected.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Consistent with hyperammonemia, vomiting, death in infancy/childhood, and elevated urinary carboxylic acids. May also have hyperglycinemia and abnormal acylcarnitine profile.

2. Methylmalonic acidemia: Shares many features with propionic acidemia including hyperammonemia, vomiting, metabolic decompensation, and elevated urinary organic acids. Hyperglycinemia would be less common.

3. Urea cycle disorders (e.g., OTC deficiency, CPS1 deficiency): The hyperammonemia, vomiting, and early death fit with a urea cycle defect. Additional findings may include respiratory alkalosis, low BUN, and orotic aciduria.

4. Nonketotic hyperglycinemia: The hyperglycinemia and hyperglycinuria are hallmarks of this condition. Patients can also have hyperammonemia, seizures, and early death. Ichthyosis would be atypical.

5. Isovaleric acidemia: Another organic acidemia to consider given the hyperammonemia, vomiting, and elevated urinary carboxylic acids. The acylcarnitine profile would show elevated isovalerylcarnitine. Hyperglycinemia is not typical.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with intellectual disability, motor delay, abnormal facial features, elevated carboxylic acids, and potential for early death. May also present with seizures, cardiomyopathy, and pancytopenia, which were not reported.

2. Methylmalonic acidemia: Matches the reported developmental delays, abnormal facial features, elevated carboxylic acids, and risk of childhood death. Additional symptoms may include seizures, metabolic acidosis, and megaloblastic anemia.

3. Glutaric acidemia type 1: Aligns with the motor delay, intellectual disability, abnormal skull shape (macrocephaly), and elevated urinary carboxylic acids. Dystonia and subdural hematomas are common but were not mentioned.

4. 3-Methylcrotonyl-CoA carboxylase deficiency: Consistent with intellectual disability, motor delay, and elevated urinary carboxylic acids. Seizures, hypotonia, and skin rash may also occur but were not reported.

5. Multiple carboxylase deficiency (biotinidase deficiency): Matches the intellectual disability, motor delay, abnormal facial features, and elevated carboxylic acids. Hearing loss, vision problems, and skin rash are additional common symptoms not present in this case.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Symptoms consistent with this diagnosis include hypergalactosemia, liver failure, prolonged PTT, intellectual disability, and death in infancy. Key symptoms not reported include cataracts and sepsis.

2. Tyrosinemia type 1: Fits with the liver failure, intellectual disability, abnormal amino acids, and early death. Additional symptoms can include renal dysfunction and peripheral neuropathy.

3. Ornithine transcarbamylase deficiency (urea cycle disorder): The patient's intellectual disability, liver failure, and early death align with this. Characteristic symptoms also include hyperammonemia and respiratory alkalosis.

4. Niemann-Pick disease type C: Explains the liver dysfunction, developmental delays, and premature death. Patients may also have vertical gaze palsy and cerebellar ataxia.

5. Zellweger spectrum disorder: Matches the patient's intellectual disability, liver dysfunction, and early death. Other features include vision/hearing impairment and facial dysmorphism.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"1. Citrullinemia Type 1: Matches the patient's hyperammonemia, elevated citrulline, neonatal presentation, and high mortality. Other typical features like vomiting, lethargy and coma are not mentioned.

2. Prolinemia Type 2: The abnormal proline level fits, as do the neonatal issues and childhood mortality risk. However, the degree of hyperammonemia and presence of citrullinemia are atypical.  

3. Argininosuccinic Aciduria: Another urea cycle defect that causes hyperammonemia, elevated citrulline, and high infant mortality. Seizures, intellectual disability and brittle hair are not noted here.

4. Ornithine Transcarbamylase Deficiency: Males with the severe form can have hyperammonemia and neonatal death. However, this usually does not cause elevated citrulline or proline.

5. Pyruvate Carboxylase Deficiency: Can present in infancy with lactic acidosis, hyperammonemia, and early death. The amino acid abnormalities are less typical of this condition though.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, liver failure leading to death in infancy/childhood if untreated. Can also cause renal tubular dysfunction which may elevate carboxylic acids.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Rarely presents with severe symptoms in infancy, but could explain death in childhood. Additional symptoms may include seizures, eczema, musty body odor.

3. Hereditary hemochromatosis: Genetic disorder causing iron overload. Decreased ferritin is atypical, but abnormal iron metabolism could still be contributing to symptoms. Usually presents in adulthood, but juvenile forms exist. Other symptoms include liver disease, diabetes, heart failure.

4. Acute intermittent porphyria (AIP): Inherited porphyria causing abdominal pain, psychiatric symptoms, seizures, red/brown urine. Life-threatening attacks could explain deaths. Typically presents after puberty, so early onset would be unusual. Fever is not typical.

5. Glutaric acidemia type I: Disorder of lysine and tryptophan metabolism causing elevated carboxylic acids, brain atrophy, and seizures. Usually presents in infancy with feeding difficulties and hypotonia. Death can occur from metabolic crisis. Additional symptoms may include large head size, subdural hemorrhage.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Characterized by lethargy, hypotonia, tremor, opisthotonus, and drowsiness in the neonatal period. Elevated leucine levels and a distinctive sweet body odor are hallmarks. Can be fatal if untreated.

2. Propionic acidemia: Can present with lethargy, hypotonia, and death in infancy. Elevated urinary carboxylic acids are a key finding. Tremor and opisthotonus are less common but can occur.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with lethargy, hypotonia, and elevated urinary carboxylic acids. Can also cause death in infancy.

4. Isovaleric acidemia: Another organic acidemia that can cause lethargy, hypotonia, and a characteristic sweaty feet odor. Elevated urinary C5 carboxylic acid is diagnostic. Tremor and opisthotonus are not typical.

5. Glutaric aciduria type 1: Can present with hypotonia, lethargy, and a high-pitched cry in infancy. Opisthotonus and a characteristic ""sweaty feet"" odor may occur. Tremor is not a classic finding. Elevated urinary glutaric acid and 3-hydroxyglutaric acid aid diagnosis.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Neonatal hemochromatosis: generalized hypotonia, anemia, premature birth, neonatal death, decreased ferritin and iron concentrations

2. Tyrosinemia type 1: hypertyrosinemia, hypotonia, failure to thrive, risk of early death; can also have liver dysfunction and renal tubular acidosis

3. Phenylketonuria (PKU): hyperphenylalaninemia, intellectual disability, hypotonia, microcephaly, seizures, fair complexion; requires early detection and dietary modification

4. Zellweger spectrum disorders: hypotonia, poor feeding, abnormal liver function, vision/hearing impairment, skeletal abnormalities; can be life-threatening in severe cases

5. Maternal vitamin D deficiency: pregnancy exposure, abnormal vitamin D metabolism, hypotonia, poor growth, increased risk of neonatal complications; can lead to rickets in infants",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Consistent with facial dysmorphism, developmental delays, behavioral issues, skeletal anomalies, and elevated 7-dehydrocholesterol. Missing typical 2-3 toe syndactyly.

2. Inborn error of cholesterol metabolism (other than SLOS), e.g. desmosterolosis: Explains abnormal cholesterol levels and potentially some developmental issues. Less likely to cause the facial and skeletal features seen.

3. Cornelia de Lange syndrome: Could explain facial features, growth and developmental delays, and behavioral problems. However, cholesterol abnormalities are not typical. Usually see more significant limb defects.

4. Chromosomal disorder, e.g. partial trisomy: Depending on the specific chromosomes involved, could cause a similar constellation of dysmorphic features and delays. Less likely to target cholesterol pathways specifically.

5. CHARGE syndrome: Associated with dysmorphic features, developmental delays, and sensory impairments. Can have limb anomalies but cholesterol abnormalities would be atypical. Usually see coloboma and choanal atresia.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: The patient's methylmalonic acidemia, aciduria, and decreased methylmalonyl-CoA mutase activity are diagnostic of this condition. Other consistent symptoms include intellectual disability, motor delay, failure to thrive, metabolic acidosis, hyperammonemia, and acute kidney injury. Typical symptoms not reported include pancreatitis and optic nerve atrophy.

2. Propionic acidemia: Features consistent with propionic acidemia include intellectual disability, hypotonia, failure to thrive, anemia, metabolic acidosis, hyperammonemia, hypoglycemia, and acute kidney injury. However, the patient's methylmalonic acidemia and aciduria are more specific for methylmalonic acidemia.

3. Cobalamin C, D, or F deficiency: These disorders can cause methylmalonic acidemia and aciduria, intellectual disability, failure to thrive, anemia, metabolic strokes, and renal disease. Additional findings may include homocystinuria, megaloblastic anemia, and retinopathy.  

4. Glycine encephalopathy: The patient's hyperglycinemia, hyperglycinuria, intellectual disability, hypotonia, and failure to thrive could suggest glycine encephalopathy. However, this would not explain the methylmalonic acidemia and aciduria.

5. Glutaric acidemia type 1: Some symptoms that overlap with the patient's presentation include intellectual disability, motor delay, hypotonia, failure to thrive, and metabolic acidosis. Key features not reported are macrocephaly, dystonia, and glutaric aciduria.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: Characterized by ataxia, hypotonia, lethargy, intellectual disability, seizures, and uraciluria. Can be fatal in infancy without treatment.

2. Dihydropyrimidinase deficiency: Symptoms include hypotonia, drowsiness, developmental delay, and abnormal uracil levels. Fewer than 20 cases reported worldwide.

3. Beta-ureidopropionase deficiency: Rare disorder causing intellectual disability, hypotonia, ataxia, and abnormal pyrimidine levels. Symptoms present in infancy.

4. Hereditary orotic aciduria: Pyrimidine synthesis disorder leading to hypotonia, developmental delay, and orotic acid crystalluria. Anemia and immune deficiency also occur.

5. Mitochondrial DNA depletion syndrome: Group of disorders causing progressive muscle weakness, hypotonia, and organ dysfunction. Can be fatal in infancy. Some forms impact pyrimidine metabolism.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Nonketotic hyperglycinemia (NKH): Characterized by abnormal glycine metabolism leading to elevated glycine levels. Consistent with this patient's abnormal glycine concentration, hyperammonemia, and high mortality in infancy. Does not explain abnormal carnitine level.

2. Propionic acidemia: Defect in propionate metabolism causing hyperammonemia, abnormal glycine and carnitine profiles, and high risk of death in infancy/childhood if untreated. Matches all of the patient's reported symptoms.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with hyperammonemia, metabolic abnormalities, and potential for infant/childhood mortality. May have additional features like pancytopenia and renal disease not reported here.

4. Carnitine uptake defect: Leads to low carnitine levels and can present in infancy with hyperammonemia, metabolic abnormalities, and risk of early death. Consistent with abnormal carnitine in this patient but wouldn't explain elevated glycine.

5. Argininosuccinic aciduria: Urea cycle defect causing hyperammonemia and abnormal glycine levels. Can have infant onset with high mortality if untreated. Wouldn't typically cause carnitine abnormalities.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Characterized by seizures, hypotonia, elevated urinary propionylcarnitine and methylcitrate, and often presents in the neonatal period with risk of death if untreated. Patient's symptoms fit this diagnosis.

2. Methylmalonic acidemia: Also presents with seizures, hypotonia, and elevated methylmalonic acid in urine. Can be life-threatening in infancy without treatment. Matches patient's presentation.

3. Isovaleric acidemia: Another organic acidemia with symptoms of seizures, hypotonia, and a characteristic ""sweaty feet"" odor. Elevated isovalerylcarnitine and isovalerylglycine in urine. Patient's symptoms consistent but odor not mentioned.

4. Glutaric acidemia type 1: Characterized by hypotonia, dystonia, and risk of striatal injury during acute decompensation. Elevated glutaric acid in urine. Some similarities to patient's presentation but dystonia not reported.

5. Multiple carboxylase deficiency: Presents with seizures, hypotonia, and elevated multiple carboxylic acids (e.g. 3-hydroxyisovaleric acid, 3-methylcrotonylglycine) in urine due to defects in biotin metabolism. Fits patient's symptoms and lab findings.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased free carnitine, impaired fatty acid oxidation, and risk of sudden death in infancy/childhood. Patient did not report episodes of hypoglycemia or vomiting, which can occur during illness.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Also causes decreased free carnitine and impaired long-chain fatty acid oxidation. Can present with cardiomyopathy or liver dysfunction, which were not mentioned.

3. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: The decreased 3-hydroxyacyl-CoA dehydrogenase activity fits. Rhabdomyolysis, hypoglycemia, and liver abnormalities are common but not reported here.

4. Carnitine uptake defect (primary carnitine deficiency): Could explain the low free carnitine but would not directly cause decreased 3-hydroxyacyl-CoA dehydrogenase. Usually presents with cardiomyopathy and muscle weakness.

5. Multiple acyl-CoA dehydrogenase deficiency (MADD/glutaric aciduria type 2): Can cause deficiencies of multiple acyl-CoA dehydrogenases and low carnitine. Severe forms have high mortality. Hypoglycemia, metabolic acidosis, and organic aciduria are typical.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Presents with poor feeding, lethargy, metabolic acidosis, hypervalinemia, hyperleucinemia, hyperisoleucinemia, and a characteristic maple syrup body odor. Can lead to seizures, coma, and death if untreated. Patient's neurological symptoms and metabolic profile fit this diagnosis.

2. Propionic acidemia: Can present with poor feeding, hypotonia, seizures, and episodes of metabolic acidosis and hyperammonemia. Dyspnea, apnea, and opisthotonus during acute decompensation. Spastic tetraplegia and motor delay in those who survive. Patient has many features consistent with this.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with hypotonia, seizures, metabolic acidosis, hyperammonemia, and breathing abnormalities. Can also lead to spastic tetraplegia and motor delay. Fits many of patient's symptoms.

4. Isovaleric acidemia: Another organic acidemia characterized by poor feeding, hypotonia, seizures, and episodes of metabolic acidosis and a characteristic ""sweaty feet"" odor. Can cause motor delay and intellectual disability. Some of patient's symptoms match this condition.

5. Glutaric acidemia type 1: Presents with motor delay, hypotonia, and episodes of metabolic acidosis and dystonia. Can develop spastic tetraplegia. Seizures and death in infancy/childhood can occur. Patient has some features of this condition.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Intellectual disability, osteoporosis, anemia, hyperammonemia, increased BUN/creatinine, body odor, early death. Key features not reported include vomiting, lethargy, cardiomyopathy.

2. Homocystinuria: Intellectual disability, skeletal abnormalities (osteoporosis, kyphoscoliosis), severe short stature, cerebral atrophy, hearing impairment. Lacking eye findings like ectopia lentis.

3. Phenylketonuria (PKU): Intellectual disability, psychosis, cerebral atrophy, hyperalaninemia, body odor. No report of seizures, eczema, or light pigmentation.

4. Niemann-Pick disease type C: Psychosis, intellectual decline, cerebral atrophy, hearing loss. Hepatosplenomegaly and vertical gaze palsy are key missing features.  

5. Mucopolysaccharidosis (e.g. Hunter syndrome): Intellectual disability, skeletal deformities (kyphoscoliosis, short stature), hearing loss. No mention of coarse facies, hepatosplenomegaly, cardiac valve disease.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: The patient's intellectual disability, seizures, ataxia, tremor, and confirmed L-2-hydroxyglutaric aciduria are all consistent with this rare neurometabolic disorder. The condition typically presents in childhood with progressive neurological deterioration.

2. Canavan disease: This leukodystrophy can cause intellectual disability, seizures, and early death. However, the patient's ataxia, tremor, and L-2-hydroxyglutaric aciduria are not typical of Canavan disease.

3. Glutaric aciduria type 1: Intellectual disability and seizures can occur, but this disorder more commonly causes macrocephaly and dystonia rather than ataxia and tremor. L-2-hydroxyglutaric aciduria would not be expected.

4. Mitochondrial encephalomyopathy: Various mitochondrial disorders can present with intellectual disability, seizures, ataxia, and other neurological deficits. However, L-2-hydroxyglutaric aciduria is not a feature of mitochondrial disease.

5. Rett syndrome: This condition can cause intellectual disability, seizures, and early mortality in childhood. However, it primarily affects girls and is characterized by repetitive hand movements and regression after initial normal development, which were not described in this patient. L-2-hydroxyglutaric aciduria is also not associated with Rett syndrome.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Matches motor delay and elevated aspartate levels. Key feature not reported is macrocephaly (enlarged head).

2. Argininosuccinic aciduria: Consistent with hyperammonemia causing neurological symptoms and early death. Would expect to see elevated argininosuccinic acid levels.

3. Methylmalonic acidemia: Can present with developmental delay, metabolic crisis, and early death. Screening would show increased methylmalonic acid.

4. Propionic acidemia: Similar presentation to methylmalonic acidemia with motor delay and risk of death in infancy. Propionic acid levels would be high.

5. Citrullinemia type I: Another urea cycle defect leading to ammonia buildup, neurological deterioration and early mortality. Marked by elevated citrulline on metabolic testing.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Citrullinemia type I: Elevated plasma citrulline, hyperammonemia, death in infancy
2. Ornithine transcarbamylase (OTC) deficiency: Hyperammonemia, increased total bilirubin, neonatal death. Plasma citrulline may not be as high as in citrullinemia.
3. Carbamoyl phosphate synthetase I (CPS1) deficiency: Hyperammonemia, neonatal death. Citrulline would be low/absent in contrast to this patient.  
4. Propionic acidemia (severe neonatal form): Hyperammonemia, increased total bilirubin, neonatal death. Plasma citrulline not typically elevated.
5. Methylmalonic acidemia (severe neonatal form): Hyperammonemia, neonatal death. Increased methylmalonic acid rather than citrulline would be expected.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Lethargy, vomiting, metabolic acidosis, hypoglycemia, hyperammonemia, and 3-methylglutaric aciduria are characteristic. May also have seizures, developmental delays.

2. Methylmalonic acidemia: Presents similarly to propionic acidemia with lethargy, metabolic acidosis, hyperammonemia, hepatomegaly, and failure to thrive. Methylmalonic acid is characteristically elevated.

3. Glutaric acidemia type 1: Causes metabolic acidosis, hypoglycemia, dicarboxylic aciduria, and 3-methylglutaric aciduria. Can have severe neurological crises and a distinctive ""batwing"" appearance on brain imaging.

4. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Presents with lethargy, vomiting, hypoglycemia, and hepatomegaly. Dicarboxylic aciduria is common. Sleep abnormalities and viral infections can trigger episodes.

5. Multiple carboxylase deficiency (biotinidase deficiency): Can cause lethargy, hypotonia, seizures, metabolic acidosis, organic aciduria, and skin rash. Responds well to biotin supplementation if diagnosed early.",Hereditary metabolic disorders
['Cystinuria'],"1. Niemann-Pick disease type A: Characterized by hepatosplenomegaly, failure to thrive, and progressive neurodegeneration leading to death usually by 3 years of age. Consistent with patient's splenomegaly and death in infancy. May have cherry-red spot on retinal exam.

2. Zellweger spectrum disorders: Group of rare congenital disorders causing severe neurological dysfunction, seizures, vision/hearing impairment, and liver dysfunction. Often fatal in infancy or early childhood. Matches patient's seizures, early death, and multi-organ involvement.

3. Krabbe disease (globoid cell leukodystrophy): Autosomal recessive lysosomal storage disorder causing progressive neurologic deterioration. Infantile form presents with irritability, seizures, feeding difficulties, vision loss, and death usually by age 2. Explains patient's seizures and early death.

4. Alpers syndrome: Rare neurologic disorder causing progressive cerebral degeneration, refractory seizures, liver dysfunction, and respiratory compromise. Typically presents in infancy or early childhood. Matches patient's seizures, respiratory issues, and death in infancy. 

5. Mitochondrial DNA depletion syndromes: Group of autosomal recessive disorders causing progressive multi-organ dysfunction due to impaired mitochondrial function. Can present with seizures, respiratory failure, and early death. May have liver failure or dysfunction of other organs/systems.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Intellectual disability, motor delay, hypotonia, hyperammonemia, feeding difficulties, methylmalonic aciduria, death in infancy/childhood. May also see metabolic acidosis and pancytopenia.

2. Propionic acidemia: Intellectual disability, hypotonia, hyperammonemia, feeding problems, abnormal amino acids, methylmalonic aciduria, early death. Metabolic stroke and cardiomyopathy are additional features not reported here.

3. Isovaleric acidemia: Intellectual disability, hypotonia, hyperammonemia, vomiting, abnormal amino acids (leucine), recurrent infections. Typically presents with a ""sweaty feet"" odor not mentioned.

4. Ornithine transcarbamylase deficiency: Intellectual disability, hypotonia, hyperammonemia, vomiting, increased BUN, low protein, early death. Seizures and respiratory alkalosis are common but not noted.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: Intellectual disability, hypotonia, feeding problems, abnormal amino acids, methylmalonic aciduria. Usually milder course than other organic acidemias. Skin changes and alopecia not reported.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, elevated urinary carboxylic acid (succinylacetone), can cause death in infancy/childhood if untreated. Missing symptom: liver dysfunction.

2. Phenylketonuria (PKU): Hyperphenylalaninemia, can cause intellectual disability and other problems if untreated. Missing symptoms: musty odor, light pigmentation, eczema.

3. Hawkinsinuria: Rare disorder of tyrosine metabolism causing hypertyrosinemia and metabolic acidosis. Consistent with elevated urinary carboxylic acid. 

4. Alkaptonuria: Disorder of tyrosine and phenylalanine metabolism. Causes darkening of urine, arthritis, and heart valve problems - not reported in this patient.

5. Severe combined immunodeficiency (SCID): Could explain recurrent viral infections and early death. However, the metabolic abnormalities are not typical of SCID.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Inherited metabolic disorder causing intellectual disability, hyperphenylalaninemia, lighter skin/hair, and musty body odor. Other features can include microcephaly, seizures, and behavioral problems. Patient's strabismus and obesity are atypical.

2. Tyrosinemia type I: Rare inherited metabolic disorder of tyrosine catabolism causing liver failure, renal dysfunction, rickets, and intellectual disability. Acute presentation in infancy with failure to thrive and death is common. Hypertyrosinemia matches, but many other typical features are not reported.

3. Zellweger spectrum disorders: Group of rare congenital disorders of peroxisome biogenesis. Severe forms present in infancy with hypotonia, seizures, vision/hearing impairment, and skeletal abnormalities. Can have multisystem involvement and early death. Some features match but many are missing.

4. Prader-Willi syndrome: Complex genetic disorder characterized by hypotonia, intellectual disability, short stature, small hands/feet, hypogonadism, and obesity. Strabismus can occur. High mortality not typical unless due to complications of obesity. Missing other cardinal features.

5. VACTERL association: Disorder characterized by multiple congenital malformations, including vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, and limb abnormalities. Can be associated with prenatal abnormalities and intellectual disability in some cases. Many typical features not reported in this patient.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's hyperammonemia, vomiting, and oroticaciduria. This X-linked urea cycle disorder can cause severe symptoms in infancy. Additional symptoms may include lethargy, coma, and intellectual disability.

2. Hereditary orotic aciduria: Consistent with the patient's oroticaciduria and potentially the hyperammonemia and vomiting. This autosomal recessive disorder of pyrimidine synthesis can present in infancy with failure to thrive, developmental delay, and anemia.

3. Citrullinemia type I: Could explain the hyperammonemia, vomiting, and potentially the infant death. This autosomal recessive urea cycle disorder typically presents in the newborn period with poor feeding, vomiting, lethargy, and coma. Oroticaciduria would be expected.

4. Argininosuccinic aciduria: Another possibility given the hyperammonemia and vomiting. This autosomal recessive condition impairs the urea cycle and typically presents in early infancy with lethargy, seizures, and coma. Oroticaciduria and coagulation abnormalities can occur.

5. Factor VII deficiency: The patient's abnormal bleeding and coagulation cascade abnormality raise suspicion for a bleeding disorder like this autosomal recessive condition. However, it would not explain the hyperammonemia or oroticaciduria.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-Hydroxyglutaric Aciduria: Characterized by elevated L-2-hydroxyglutaric acid, intellectual disability, hypotonia, seizures, and abnormal white matter on MRI. Consistent with patient's L-2-hydroxyglutaric acidemia, intellectual disability, hypotonia, and abnormal myelination.

2. Ornithine Transcarbamylase (OTC) Deficiency: An inherited urea cycle disorder causing hyperammonemia, intellectual disability, hypotonia, seizures, and early death. Matches patient's hyperammonemia, intellectual disability, hypotonia, and death in childhood. 

3. Canavan Disease: A leukodystrophy causing intellectual disability, hypotonia, macrocephaly, and hyperreflexia. White matter degeneration on MRI. Fits patient's intellectual disability, hypotonia, hyperreflexia, and abnormal myelination. Patient is not reported to have macrocephaly.

4. Glutaric Aciduria Type 1: Disorder of lysine and tryptophan metabolism causing macrocephaly, intellectual disability, hypotonia, and dystonia. Hyperammonemia and white matter abnormalities can occur. Matches patient's intellectual disability, hypotonia, hyperammonemia, and abnormal myelination. No dystonia or macrocephaly reported.

5. Alexander Disease: A leukodystrophy causing intellectual disability, hypotonia, hyperreflexia, macrocephaly, and seizures. Characteristic white matter abnormalities on MRI. Consistent with patient's intellectual disability, hypotonia, hyperreflexia, and abnormal myelination. Macrocephaly and seizures not reported.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by absence or underdevelopment of the cerebellar vermis, leading to ataxia, developmental delay, and intellectual disability. Additional features like abnormal breathing and eye movements are not reported here.

2. Zellweger spectrum disorders: Group of rare genetic disorders causing severe neurological dysfunction, intellectual disability, and potentially life-threatening complications in infancy. Absence of other key features like vision/hearing loss, seizures, and liver dysfunction.

3. COL4A1-related disorders: Genetic conditions involving dysfunction of collagen, a key protein in blood vessels and other tissues. Can cause stroke-like episodes, cerebral atrophy, intellectual disability, and other variable symptoms. Specific facial features and eye abnormalities not noted.

4. Congenital disorder of glycosylation (CDG): Rare group of genetic disorders affecting glycosylation, an important process for protein and tissue development. Can cause cerebellar atrophy, stroke-like episodes, intellectual disability, and early death. Other characteristic symptoms like failure to thrive and vision abnormalities not reported.  

5. MELAS syndrome: Mitochondrial disorder that can present with stroke-like episodes, intellectual decline, and potentially cerebellar atrophy. Onset is often in childhood after a period of normal development. Other common features like short stature, hearing loss, and diabetes are not mentioned.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause liver failure, renal dysfunction, and neurological problems in infancy if untreated. Consistent with premature birth, neonatal death, and infant death.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Classic PKU is usually not fatal in infancy, but a severe form could potentially explain the other symptoms.

3. Alkaptonuria: A rare disorder of tyrosine metabolism that causes buildup of homogentisic acid. Usually has a milder course but in severe cases could lead to ochronosis and early death.

4. Maple syrup urine disease: Causes buildup of branched-chain amino acids and their toxic metabolites. Can be fatal in infancy if untreated. Patient's symptoms are atypical but a severe presentation is possible.

5. Tyrosinemia type II (Richner-Hanhart syndrome): Characterized by hypertyrosinemia, eye and skin lesions, and intellectual disability. Rarely fatal in infancy but a severe case could potentially fit this presentation.",Hereditary metabolic disorders
['Propionic acidemia'],"1+ Propionic acidemia: Consistent with developmental delay, hypotonia, seizures, lethargy, hyperammonemia, abnormal amino acids. Key features not reported include ketoacidosis and cardiomyopathy.

2+ Ornithine transcarbamylase deficiency: Matches intellectual disability, seizures, lethargy, hyperammonemia, increased BUN, vomiting. Lacking report of protein aversion and liver dysfunction.

3+ Biotinidase deficiency: Aligns with seizures, hypotonia, developmental delay, hearing loss, hyperammonemia, lactic acidosis. No mention of skin rash, alopecia, or ataxia.

4+ Methylmalonic acidemia: Explains developmental delay, lethargy, hypotonia, vomiting, hyperammonemia, metabolic acidosis. Missing features include pancytopenia and renal dysfunction.

5+ Severe combined immunodeficiency (SCID): Accounts for recurrent infections, early death, failure to thrive, pneumonia. However, lacks typical features like chronic diarrhea and opportunistic infections.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson's disease: Characterized by low ceruloplasmin and copper levels, liver dysfunction (elevated transaminases), and often presenting in childhood or adolescence. Polydipsia is not a typical feature but could occur secondary to liver or neurological involvement.

2. Menkes disease: Another disorder of copper metabolism causing low copper and ceruloplasmin levels and liver dysfunction. However, it is X-linked recessive and usually presents in infancy with neurological symptoms and unique hair abnormalities not mentioned here.

3. Chronic liver disease (e.g., viral hepatitis, autoimmune hepatitis): Can cause elevated liver enzymes and lead to cirrhosis and liver failure. However, the copper abnormalities and adolescent death are not typical features.

4. Inherited metabolic disorders (e.g., galactosemia, tyrosinemia): Certain genetic conditions can lead to liver damage and failure in children and young adults. Additional symptoms and lab findings would be expected though.

5. Endocrine disorders (e.g., diabetes insipidus, SIADH): Excessive thirst can be caused by disorders affecting vasopressin/ADH or the kidneys' ability to concentrate urine. However, these conditions should not cause liver damage or copper abnormalities.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Seizures, lethargy, hypotonia, vomiting, and hyperglutaminemia are all consistent with OTC deficiency. Oroticaciduria is a key finding that strongly suggests a urea cycle disorder.

2. Carbamoyl phosphate synthetase I (CPS1) deficiency: Another urea cycle disorder that can present similarly to OTC deficiency with lethargy, poor feeding, seizures, and hyperammonemia. CPS1 deficiency does not typically cause oroticaciduria, however.

3. Methylmalonic acidemia: An organic acidemia that can present in the neonatal period with lethargy, hypotonia, vomiting, and seizures. It would not explain the oroticaciduria but could cause hyperglutaminemia.

4. Propionic acidemia: Another organic acidemia with a similar presentation to methylmalonic acidemia, including lethargy, hypotonia, vomiting, and hyperammonemia. Also would not account for the oroticaciduria.

5. Glutaric acidemia type II: A disorder of fatty acid oxidation that can present in the neonatal period with hypotonia, seizures, and metabolic acidosis. Lethargy and vomiting may occur. Oroticaciduria would be unusual but glutaric acidemia can cause a secondary hyperammonemia.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Consistent with hypergalactosemia, feeding difficulties, failure to thrive, intellectual disability, speech delay, and cataracts (not reported). Key additional symptom is liver dysfunction.

2. PKU (Phenylketonuria): Consistent with intellectual disability, motor delay, microcephaly, and hypotonia. Caused by abnormal phenylalanine metabolism. Additional symptoms include eczema, light pigmentation, and musty body odor.

3. Zellweger Spectrum Disorder: Consistent with hypotonia, intellectual disability, motor delay, and liver dysfunction (elevated ALP). Caused by peroxisomal biogenesis defects. Additional symptoms include distinctive facial features, vision/hearing impairment, and renal cysts.

4. Menkes Disease: X-linked disorder of copper metabolism. Consistent with intellectual disability, microcephaly, hypotonia, and failure to thrive. Additional symptoms include sparse, kinky hair, and seizures. 

5. Congenital Disorders of Glycosylation: Group of disorders causing abnormal glycoprotein synthesis. Consistent with intellectual disability, hypotonia, failure to thrive, and liver dysfunction. Additional symptoms vary but can include abnormal fat pads, inverted nipples, and cerebellar hypoplasia.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Urea cycle disorder: Hyperammonemia and death in childhood are key features. Obesity and foot abnormalities are not typical but could be secondary.

2. Prader-Willi syndrome: Characterized by obesity, intellectual disability, and distinctive facial features and body habitus. Foot abnormalities can occur. Hyperammonemia and childhood death are not characteristic.

3. Bardet-Biedl syndrome: Features obesity, intellectual disability, kidney dysfunction, and limb abnormalities including foot anomalies. Hyperammonemia is not typical. 

4. Beckwith-Wiedemann syndrome: Causes overgrowth, abdominal wall defects, and increased risk of childhood cancers. Hyperammonemia is not characteristic. Foot abnormalities are not a main feature.

5. Congenital lactic acidosis: Group of metabolic disorders causing toxic lactic acid and ammonia buildup. Can be fatal in childhood. Obesity and foot abnormalities are not typical features.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Rare genetic disorder causing abnormal aspartate metabolism, leading to abnormal myelination, developmental delay, feeding problems, and early death. Key symptom not reported: macrocephaly.

2. Phenylketonuria (PKU): Inherited disorder of amino acid metabolism causing intellectual disability, behavioral problems, and lighter skin/hair. Abnormal aspartate levels may be seen. Key symptoms not reported: seizures, skin rash.

3. Maple syrup urine disease: Inherited disorder of branched-chain amino acid metabolism, causing poor feeding, lethargy, developmental delay, and maple syrup odor to urine. Can be fatal if untreated. Abnormal aspartate levels may occur.

4. Leukodystrophy (e.g. Krabbe disease): Group of disorders causing abnormal myelination, leading to developmental delay, feeding problems, muscle weakness and early death. Key symptom not reported: vision/hearing problems.

5. Mitochondrial disorder: Group of disorders caused by mitochondrial dysfunction, with symptoms including developmental delay, feeding problems, muscle weakness, and increased risk of early death. Can cause secondary amino acid abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Consistent with hyperphenylalaninemia, abnormal prenatal development, and risk of intellectual disability and neurological problems if untreated. Key symptoms not reported include musty body odor, fair skin/hair, and hyperactivity.

2. Tetrahydrobiopterin (BH4) deficiency: Can cause hyperphenylalaninemia and neurological dysfunction similar to PKU. Additional symptoms may include microcephaly, hypotonia, and autonomic dysfunction.

3. Maternal phenylketonuria: Uncontrolled high phenylalanine levels in the mother during pregnancy can cause birth defects, intellectual disability, and early death in the infant. Maternal PKU symptoms were not reported.

4. Zellweger spectrum disorder: A group of rare congenital disorders that can cause abnormal brain development, hypotonia, seizures, and early death. May have characteristic facial features and liver dysfunction.

5. Trisomy 13 (Patau syndrome): A chromosomal disorder causing severe intellectual disability, congenital heart defects, brain/spinal cord malformations, and very limited life expectancy. Additional symptoms may include cleft lip/palate, microphthalmia, and polydactyly.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Delayed development, hyperphenylalaninemia. Can also have microcephaly, seizures, and light pigmentation not reported here.

2. Tyrosinemia type I: Hypertyrosinemia, risk of early death. Other features can include liver failure, renal dysfunction, and peripheral neuropathy.

3. Maple syrup urine disease (MSUD): Neonatal onset, risk of death in infancy if untreated. Causes elevated branched-chain amino acids and neurological deterioration.

4. Homocystinuria: Developmental delay, early mortality. Can also have skeletal abnormalities, eye problems, and thromboembolism. Specific amino acids not reported.

5. Glutaric aciduria type 1: Abnormal development, high mortality risk. Typically presents with macrocephaly and dystonia/dyskinesia after acute decompensation. Amino acid levels not specified.",Hereditary metabolic disorders
[],"1. Noonan syndrome: Characterized by congenital heart defects (especially pulmonic stenosis), cardiomyopathy, renal anomalies, and hypotonia. Other features like short stature and facial dysmorphism were not mentioned.

2. Barth syndrome: X-linked disorder causing cardiomyopathy, hypotonia, and cyclic neutropenia (not mentioned). Ventricular septal defects and renal problems can occur. Typically affects males and can be lethal in infancy.

3. Pompe disease (glycogen storage disease type II): Autosomal recessive disorder with infantile-onset hypotonia, cardiomyopathy, and high mortality. Key features not reported include enlarged tongue and liver.

4. Zellweger spectrum disorders: Group of rare autosomal recessive conditions with hypotonia, brain malformations (not mentioned), liver dysfunction (not mentioned), and renal cysts. Cardiac defects and early lethality can occur in severe cases.

5. LEOPARD syndrome: Shares features with Noonan syndrome like pulmonic stenosis and hypertrophic cardiomyopathy. Also characterized by skin lentigines (not mentioned), ocular hypertelorism (not mentioned), and sensorineural deafness (not mentioned).",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, intellectual disability, and fair complexion. The patient's elevated phenylalanine levels and neurological symptoms are consistent, but death in infancy would be atypical for PKU alone.

2. Tyrosinemia type I: Features hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and peripheral neuropathy. Matches the patient's elevated tyrosine, though additional symptoms of liver and kidney disease were not reported.

3. Maple syrup urine disease (MSUD): Presents with poor feeding, vomiting, lethargy, dystonia, and a characteristic maple syrup odor to the urine. The neurological symptoms fit, but the patient's elevated tyrosine and phenylalanine are not typical of MSUD.

4. Glutaric aciduria type 1: Causes macrocephaly, dystonia, spasticity, and intellectual disability. The spasticity matches the patient's presentation. Urine organic acid analysis could detect the diagnostic glutaric acid elevation.

5. Mitochondrial disorder: Can manifest with a wide range of symptoms including muscle weakness, seizures, developmental delays, and increased susceptibility to illness. The patient's neurological issues and recurrent infections could fit this diagnosis, but the specific amino acid elevations are less consistent.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, failure to thrive, liver dysfunction, renal tubular dysfunction, and risk of early death. Consistent with the patient's hypertyrosinemia, developmental issues, and mortality.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and severe intellectual disability if untreated. Matches the patient's hyperphenylalaninemia and delayed development. However, PKU is not typically fatal in infancy or childhood if treated.

3. Maple syrup urine disease (MSUD): Features poor feeding, lethargy, hypotonia, developmental delay, and risk of metabolic decompensation and death. Aligns with the patient's hypotonia, delay, and early mortality. Elevated branched-chain amino acids would be expected rather than hypertyrosinemia/hyperphenylalaninemia.

4. Pyruvate dehydrogenase deficiency: Mitochondrial disorder causing lactic acidosis, hypotonia, seizures, and progressive neurological deterioration. Matches the patient's hypotonia, developmental issues, and potential for childhood death. Additional symptoms like lactic acidosis and seizures are not reported.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder characterized by craniofacial abnormalities, hypotonia, seizures, liver dysfunction, and early death. Consistent with the patient's abnormal prenatal development, hypotonia, and mortality. Lacks other typical features like liver cysts and hearing/vision impairment.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Seizures, encephalopathy, opisthotonus, glutaric aciduria, elevated glutaric acid, early mortality. May also have macrocephaly and basal ganglia injury on brain imaging.

2. Propionic acidemia: Encephalopathy, seizures, early mortality, decreased plasma carnitine. However, this would cause propionic aciduria rather than glutaric aciduria.

3. Methylmalonic acidemia: Encephalopathy, seizures, early mortality, decreased plasma carnitine. Methylmalonic acid would be elevated rather than glutaric acid.

4. Canavan disease: Seizures, encephalopathy, early mortality. An inherited leukodystrophy that can cause elevated urine glutaric acid. However, the primary metabolite is N-acetylaspartic acid.

5. Epileptic encephalopathy: Seizures, encephalopathy, early mortality. While this could explain some symptoms, it would not account for the glutaric aciduria and metabolic disturbances.",Hereditary metabolic disorders
[],"1. Menkes disease: Explains neurological abnormalities, unusual hair, infant death, and multi-organ dysfunction. Key features not reported include tortuous blood vessels and bone abnormalities.

2. Krabbe disease: Accounts for motor delay, spasticity, vision/hearing issues, seizures, and early death. Does not explain the hair changes.

3. Zellweger syndrome: Matches the hypotonia, seizures, vision/hearing loss, dysmorphic features, and hepatomegaly. Renal cysts are a key feature not mentioned.

4. Maple syrup urine disease: The metabolic acidosis, hyperactivity, spasticity, and intellectual disability fit, but the hair changes and vision issues are not typical.

5. Canavan disease: Explains the hypotonia, head lag, seizures, and leukodystrophy. Macrocephaly is a cardinal sign not reported here.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Cerebrotendinous xanthomatosis (CTX): Rare lipid storage disorder causing neurological deterioration (ataxia, intellectual disability, hypotonia), cataracts, diarrhea, and tendon xanthomas. Patient's neurological symptoms fit but no mention of cataracts, diarrhea or xanthomas.

2. Niemann-Pick disease type C (NPC): Lysosomal storage disorder with progressive neurological decline (ataxia, dysarthria, cognitive impairment), vertical gaze palsy, and hepatosplenomegaly. Explains neurological and hepatic features but patient lacks report of vertical gaze palsy or enlarged liver/spleen.

3. Congenital disorders of glycosylation (CDGs): Group of disorders causing neurological impairment (hypotonia, ataxia, seizures, developmental delay), liver dysfunction, coagulopathy, and failure to thrive. Matches patient's neurological, hepatic and coagulation issues but no mention of failure to thrive or seizures.

4. Ataxia telangiectasia (AT): Autosomal recessive disorder with progressive cerebellar ataxia, oculomotor apraxia, immunodeficiency, and telangiectasias. Fits cerebellar degeneration but patient lacks classic eye movement abnormality, immunodeficiency and telangiectasias.

5. Infantile neuroaxonal dystrophy (INAD): Rare inherited neurological disorder with progressive psychomotor regression, hypotonia, ataxia, and vision impairment. Matches neurological decline but no report of vision loss, and hepatic/hematologic issues are atypical.",Hereditary metabolic disorders
['Canavan disease'],"1. Maple syrup urine disease: Presents with poor feeding, irritability, hypotonia, seizures, and high levels of branched-chain amino acids. Can be fatal in infancy if untreated. Patient's symptoms fit but would need to check for characteristic urine odor.

2. Phenylketonuria (PKU): Causes intellectual disability, seizures, hypotonia, and eczema if untreated. Elevated phenylalanine levels on newborn screening. Patient has many consistent symptoms but eczema not mentioned.

3. Nonketotic hyperglycinemia: Characterized by hypotonia, seizures, feeding problems, and respiratory issues in infancy. Caused by defective glycine breakdown. Patient's presentation matches but glycine levels need to be checked.

4. Glutaric aciduria type 1: Features macrocephaly, hypotonia, dystonia, and encephalopathic crises that can be fatal. Organic acid testing reveals high glutaric acid. Some shared symptoms but patient's head size is unknown.

5. Molybdenum cofactor deficiency: Rare disorder causing intractable seizures, severe developmental delays, and lens dislocation. Elevated sulfite, xanthine and hypoxanthine levels. Matches patient's neurological symptoms but no mention of eye findings.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause failure to thrive, liver dysfunction, and neurological problems in infancy. Consistent with abnormal prenatal development, neonatal complications and death, and GI issues. 

2. Phenylketonuria (PKU): A disorder of phenylalanine metabolism causing hyperphenylalaninemia. Can lead to severe intellectual disability, seizures, and behavioral problems if untreated. Matches elevated phenylalanine, though other classic symptoms like light skin/hair and musty body odor are not reported.

3. Maple syrup urine disease (MSUD): Defective metabolism of branched-chain amino acids presenting in the neonatal period with poor feeding, vomiting, lethargy, and a distinctive sweet odor to the urine. Aligns with neonatal complications and GI symptoms, but the patient's elevated tyrosine and phenylalanine are not typical of MSUD.

4. Niemann-Pick disease type A: A severe lipid storage disorder causing neurodevelopmental deterioration and death usually by age 3. Fits the pattern of abnormal development and early death, but would not characteristically cause hypertyrosinemia or hyperphenylalaninemia.

5. Zellweger syndrome: A peroxisomal biogenesis disorder causing craniofacial abnormalities, hypotonia, seizures, and liver dysfunction. Can present with neonatal complications and early death. While it may explain some of the patient's symptoms, the amino acid abnormalities reported are not classic for Zellweger syndrome.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: Presents with metabolic acidosis, cerebral edema, hyperleucinemia, and neurological deterioration leading to coma and death if untreated. Does not typically cause immunodeficiency or alopecia.

2. Canavan disease: A leukodystrophy causing abnormal white matter, hypotonia, macrocephaly, and developmental regression. Fits with cerebral edema and abnormal white matter but would not be expected to cause metabolic acidosis, hyperleucinemia or immunodeficiency.

3. Methylmalonic acidemia: Can present with metabolic acidosis, cerebral edema, hypotonia, and developmental regression. May be associated with neutropenia and pancytopenia but not typically immunodeficiency or alopecia.

4. Severe combined immunodeficiency (SCID): Characterized by recurrent, severe infections due to lack of T and B cell immunity. Can be associated with alopecia and failure to thrive but would not typically cause the neurological and metabolic abnormalities seen.

5. Urea cycle disorder (e.g. ornithine transcarbamylase deficiency): Presents with hyperammonemia, encephalopathy, cerebral edema, and respiratory alkalosis. Can progress to coma and death. Does not fit well with hyperleucinemia, immunodeficiency or alopecia.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"1. Acute intermittent porphyria: Characterized by abdominal pain and elevated urinary delta-aminolevulinic acid. Can have childhood onset but death in childhood would be atypical.

2. Congenital erythropoietic porphyria: A severe form of porphyria that can present in infancy or early childhood with hemolytic anemia, photosensitivity, and elevated porphyrin precursors. Abdominal pain is not a classic feature.

3. Hereditary coproporphyria: Another acute porphyria that can have gastrointestinal symptoms and elevated urinary delta-aminolevulinic acid. Usually presents in adulthood but earlier onset has been reported.

4. Lead poisoning: Can cause abdominal pain, anemia, and impaired heme synthesis leading to elevated delta-aminolevulinic acid. Additional symptoms may include developmental delay, irritability, and neurologic symptoms. A blood lead level test can confirm.

5. Rare mitochondrial disorder (e.g. Pearson syndrome): Can present in infancy with sideroblastic anemia, pancreatic dysfunction, and lactic acidosis. Abdominal pain and elevated delta-aminolevulinic acid are not typical features. Genetic testing would be needed for diagnosis.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Characterized by methylmalonic aciduria, metabolic acidosis, seizures, and high mortality in infancy if untreated. Can be caused by defects in methylmalonyl-CoA mutase or defects in vitamin B12 metabolism.

2. Propionic acidemia: Another organic acidemia that can present similarly with metabolic acidosis, seizures, and infant death. Key distinguishing feature is propionic aciduria rather than methylmalonic aciduria.

3. Holocarboxylase synthetase deficiency: A biotin metabolism disorder that can cause seizures, metabolic acidosis, and death in infancy. Typically also associated with skin rash and alopecia, which were not reported in this case.

4. Glutaric acidemia type 1: Can present with metabolic acidosis and seizures, but is usually associated with macrocephaly and dystonia/dyskinesia rather than methylmalonic aciduria. 

5. Molybdenum cofactor deficiency: A very rare disorder that can cause seizures, metabolic acidosis and infant death. Usually also associated with dysmorphic facial features, brain abnormalities, and dislocated lenses. Methylmalonic aciduria would be atypical.",Hereditary metabolic disorders
['Alkaptonuria'],"1. Mitochondrial disorder: Seizures, hypotonia, growth delay, neurological symptoms, and risk of childhood death are consistent with this group of genetic disorders that impair cellular energy production. Dark urine (if myoglobinuria) can also occur. Key features not mentioned include vision/hearing impairment, heart problems, diabetes, and lactic acidosis.

2. Urea cycle disorder: This group of metabolic disorders can present with lethargy, hypotonia, drowsiness, seizures, growth delay, and high risk of death due to toxic ammonia levels. Some types can cause liver dysfunction leading to dark urine. Vomiting and respiratory alkalosis are common features not reported here.

3. Krabbe disease (globoid cell leukodystrophy): Symptoms of seizures, hypotonia, growth delay, lethargy, and limited survival fit with this progressive genetic disorder that destroys the myelin sheath of nerves. Typical signs not mentioned are vision loss, irritability, and peripheral neuropathy.

4. Zellweger spectrum disorder: This group of genetic metabolic disorders is characterized by seizures, hypotonia, growth delay, liver dysfunction (causing dark urine), and risk of infant death. Hearing/vision impairment and distinctive facial features are often present but not noted here.

5. Niemann-Pick disease type A: Children with this rare lysosomal storage disorder develop seizures, loss of motor skills, lethargy, failure to thrive, and liver enlargement (possibly causing dark urine). Death usually occurs by age 3. A cherry-red spot in the eye is a telltale sign not reported in this case.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Characterized by elevated branched-chain amino acids, neurological symptoms like seizures and encephalopathy, and high risk of neonatal death if untreated. Urine may have a distinct sweet odor.

2. Isovaleric acidemia: Disorder of leucine metabolism that can present with seizures, coma, and death in severe neonatal-onset form. Characterized by elevated isovaleric acid in urine.

3. Propionic acidemia: Can present in neonatal period with seizures, coma, and death. Caused by deficiency of propionyl-CoA carboxylase. Abnormal metabolites including 3-hydroxypropionate and methylcitrate are detectable in urine.  

4. Methylmalonic acidemia: Another organic acidemia that can present with neonatal seizures and death. Caused by defects in methylmalonyl-CoA mutase or related pathways. Characterized by elevated methylmalonic acid in urine.

5. Glutaric acidemia type II: Rare disorder of fatty acid and amino acid metabolism that can present with severe neonatal form with seizures, metabolic acidosis, and early death. Characterized by elevated glutaric acid and other abnormal metabolites in urine.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with patient's hypoglycemia, hepatomegaly, and high risk of infant death. May also have low carnitine levels. Episodes often triggered by fasting or illness.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Can explain cardiomegaly, hypoglycemia, liver enlargement, and childhood mortality risk. Dicarboxylic aciduria and low carnitine levels often seen. 

3. Propionic acidemia: Features can include poor feeding, tachypnea, lethargy, hypoglycemia, and cardiomegaly. High lactate, ketones, and abnormal organic acids common. Significant risk for complications and death.

4. Methylmalonic acidemia: Similar presentation to propionic acidemia with hypoglycemia, metabolic acidosis, hyperammonemia, and abnormal organic acids. Can also have neutropenia increasing infection risk.

5. Carnitine uptake defect (primary carnitine deficiency): Leads to very low plasma carnitine levels. Can present with cardiomyopathy, hypoglycemia, and increased infection risk. Fatty liver and elevated liver enzymes often seen.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Glutaric acidemia type 1: Characterized by glutaric aciduria, metabolic acidosis, hypoglycemia, seizures, lethargy, and progressive neurologic deterioration. Can lead to death in infancy or childhood.

2. Nonketotic hyperglycinemia: Marked by elevated glycine, lethargy, hypotonia, seizures, and progressive neurologic deterioration. Sleep abnormalities are common. Usually presents in infancy.

3. Propionic acidemia: Features 3-methylglutaric aciduria, metabolic acidosis, hypoglycemia, lethargy, seizures, and progressive neurologic deterioration if untreated. Can be fatal in infancy or early childhood.

4. Methylmalonic acidemia: Causes elevated urinary carboxylic acid, metabolic acidosis, hypoglycemia, lethargy, seizures, and progressive neurologic deterioration. Can lead to death in infancy if severe and untreated.

5. MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes): Can present with seizures, lethargy, vomiting, recurrent infections, and progressive neurologic deterioration. Brain imaging abnormalities are characteristic but were not mentioned here.",Hereditary metabolic disorders
['MODY'],"1. Acute intermittent porphyria: Characterized by hypoglycemia and abnormal porphyrin levels. Glycosuria is not typical but can occur.

2. Variegate porphyria: Another acute porphyria that can present with hypoglycemia and abnormal porphyrin levels. Additional symptoms like photosensitivity and blistering skin lesions are not reported here.

3. Type 1 diabetes mellitus: The combination of hypoglycemia and glycosuria is consistent with diabetes, but the abnormal porphyrin levels would be atypical. Polyuria, polydipsia, and weight loss are other common symptoms not mentioned.

4. Drug-induced porphyria: Certain medications can trigger acute porphyria symptoms in susceptible individuals, leading to hypoglycemia and abnormal porphyrin levels. More information is needed about potential drug exposures.

5. Liver disease: Advanced liver disease can cause abnormal porphyrin metabolism. Hypoglycemia may occur with liver failure, but glycosuria would be unusual. Other signs of liver dysfunction are not reported.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Consistent with hyperphenylalaninemia, abnormal prenatal development, and risk of intellectual disability and neurological problems if untreated. Key symptoms not reported include musty body odor, fair skin/hair, and hyperactivity.

2. Tetrahydrobiopterin (BH4) deficiency: Can cause hyperphenylalaninemia and neurological dysfunction similar to PKU. Additional symptoms may include microcephaly, hypotonia, and autonomic dysfunction.

3. Maternal phenylketonuria: Uncontrolled high phenylalanine levels in the mother during pregnancy can cause birth defects, intellectual disability, and early death in the infant. Maternal PKU symptoms were not reported.

4. Zellweger spectrum disorder: A group of rare congenital disorders that can cause abnormal brain development, hypotonia, seizures, and early death. May have characteristic facial features and liver dysfunction.

5. Trisomy 13 (Patau syndrome): A chromosomal disorder causing severe intellectual disability, congenital heart defects, brain/spinal cord malformations, and very limited life expectancy. Additional symptoms may include cleft lip/palate, microphthalmia, and polydactyly.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric aciduria type 1: Matches patient's macrocephaly, dystonia, seizures, cerebral atrophy, and glutaric aciduria. Can also cause lethargy, hyperhidrosis, and death in childhood. Does not explain all symptoms.

2. Leigh syndrome (mitochondrial disease): Explains neurological symptoms like seizures, dystonia, opisthotonus, as well as cerebral atrophy, respiratory and feeding difficulties, and early mortality. Additional symptoms can include vomiting, lethargy, and sleep disturbances.  

3. Krabbe disease (leukodystrophy): Accounts for neurological deterioration with seizures, spasticity, vision loss, feeding problems, leading to death in infancy or early childhood. Also associated with fever, vomiting, and irritability. Does not fit cerebral atrophy.

4. Alexander disease: Matches macrocephaly, seizures, spasticity, developmental delays and early death. Can also present with vomiting, sleep disturbances and respiratory issues. Increased CSF protein is a key finding. Hydrocephalus present but not cerebral atrophy.

5. Aicardi-Gouti√®res syndrome: Fits hydrocephalus, seizures, dystonia, cerebral atrophy, and early mortality. Other features include fever, hepatosplenomegaly, thrombocytopenia, and skin lesions. Increased CSF lymphocytes and interferon are diagnostic clues not mentioned here.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this condition can cause failure to thrive and death in infancy or childhood if untreated. Other features like liver failure and renal tubular dysfunction are not mentioned.

2. Phenylketonuria (PKU): The patient's hyperphenylalaninemia is consistent with PKU, an inborn error of phenylalanine metabolism. However, PKU is usually not fatal in infancy if treated with a low-phenylalanine diet. Intellectual disability is a key feature not reported.

3. Maple syrup urine disease (MSUD): Another inborn error of amino acid metabolism that can be fatal in infancy, but the patient's high tyrosine and phenylalanine are not typical of MSUD. Features of MSUD like feeding difficulties, lethargy, and maple syrup odor of urine are not mentioned.

4. Zellweger spectrum disorder: This peroxisomal biogenesis disorder causes abnormal prenatal development, hypotonia, and early death. However, the patient's amino acid abnormalities are not characteristic of Zellweger syndrome.

5. Trisomy 13: This chromosomal disorder is characterized by abnormal prenatal development and multiple congenital anomalies. It is often fatal in infancy. However, the patient's hypertyrosinemia and hyperphenylalaninemia are not typical features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of hepatocellular carcinoma. Consistent with patient's hypertyrosinemia and early death.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and severe intellectual disability if untreated. Consistent with patient's hyperphenylalaninemia, but classic PKU is not typically associated with hypertyrosinemia, preeclampsia or early death.

3. Hawkinsinuria: Rare disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive. May be consistent with hypertyrosinemia and early death, but patient is not reported to have had acidosis.

4. Tyrosinemia type II: Characterized by hypertyrosinemia, corneal ulcers, and skin/hair abnormalities. Consistent with hypertyrosinemia but other key features not reported in this patient. Usually not fatal in early adulthood.

5. Alkaptonuria: Disorder of phenylalanine/tyrosine metabolism causing darkened urine, ochronosis, and arthritis. May explain hyperphenylalaninemia and hypertyrosinemia but not typically associated with preeclampsia or early death.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of early death. Consistent with the patient's hypertyrosinemia and elevated urinary carboxylic acids.

2. Phenylketonuria (PKU): Caused by impaired metabolism of phenylalanine, leading to hyperphenylalaninemia and intellectual disability if untreated. Matches the patient's hyperphenylalaninemia, but other features like liver disease are not typical of PKU.

3. Maple syrup urine disease: A disorder of branched-chain amino acid metabolism causing poor feeding, lethargy, metabolic decompensation, and a characteristic sweet odor to the urine. The patient's neonatal presentation could fit, but maple syrup urine disease does not typically cause hypertyrosinemia.

4. Glutaric aciduria type I: Characterized by elevated glutaric acid and 3-hydroxyglutaric acid, as well as neurological deterioration and brain atrophy. May explain the patient's elevated urinary organic acids, but the amino acid abnormalities are not typical.

5. Mitochondrial disorder: Mitochondrial dysfunction can cause a wide range of symptoms including metabolic abnormalities, organ dysfunction, and early death. Could potentially explain the patient's presentation, but more specific metabolic and genetic testing would be needed.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, failure to thrive, liver failure, renal dysfunction, and high risk of early death. The patient's neonatal/childhood death and hypertyrosinemia fit this diagnosis. Other symptoms not mentioned include skin/eye lesions and neurological issues.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability/developmental delay if untreated. Consistent with patient's hyperphenylalaninemia and abnormal development. Usually not fatal in infancy/childhood with modern diagnosis and treatment.

3. Maple syrup urine disease (MSUD): Leads to high levels of branched-chain amino acids and their ketoacids, causing a maple syrup odor in urine. Can present with neonatal encephalopathy, failure to thrive, and risk of infant death. Patient's neonatal death fits, but classic symptoms of sweet-smelling urine, lethargy, and seizures are not described.

4. Homocystinuria: Causes high homocysteine and methionine levels, developmental delay, visual problems, and skeletal abnormalities. Vascular events can cause early death. Some overlap with patient's symptoms but homocysteine/methionine not specifically mentioned.

5. Urea cycle disorders (e.g. OTC deficiency): Lead to hyperammonemia, encephalopathy, coma, and death, often triggered by high protein intake or stress. Could explain infant/childhood death but characteristic symptoms of vomiting, lethargy, coma not noted, and involves nitrogen metabolism rather than tyrosine or phenylalanine specifically.",Hereditary metabolic disorders
['Hereditary orotic aciduria'],"1. Urea cycle disorder: Presents with lethargy, hypotonia, vomiting, and hepatomegaly. Can have high alanine levels and ornithinuria. Usually does not have skin involvement.

2. Organic acidemia (e.g. propionic acidemia): Can cause poor feeding, lethargy, hypotonia, hepatomegaly. Fever and skin manifestations sometimes seen. Further metabolic testing needed.

3. Lysosomal storage disorder (e.g. Niemann-Pick): Hepatosplenomegaly, hypotonia, and failure to thrive are common. Some have cherry-red spot on eye exam. Skin involvement is atypical.

4. Congenital disorder of glycosylation: Can have multi-organ dysfunction, hypotonia, failure to thrive, and abnormal liver function. Skin and infectious symptoms are possible. Transferrin analysis can help diagnose.

5. Neonatal hemochromatosis: Presents with liver failure, hypotonia, and often death in infancy. Splenomegaly and ascites may be present. Skin involvement would be unusual. Ferritin levels and liver biopsy can confirm diagnosis.",Hereditary metabolic disorders
['Holocarboxylase synthetase deficiency'],"1. Propionic acidemia: Consistent with neonatal presentation, hypotonia, metabolic acidosis, hyperammonemia, propionyl-CoA carboxylase deficiency, and abnormal metabolites. May also have neutropenia, thrombocytopenia, and hypoglycemia (not reported).

2. Methylmalonic acidemia: Can cause similar symptoms as propionic acidemia, including neonatal onset, hypotonia, metabolic acidosis, hyperammonemia, and multi-organ dysfunction. Presence of methylmalonic acid in urine organic acid analysis would support this diagnosis.

3. Pyruvate carboxylase deficiency: The decreased pyruvate carboxylase activity is suggestive, and this disorder can present with metabolic acidosis, hypotonia, and early lethality. However, it typically causes severe lactic acidosis and does not fully explain the hyperammonemia and propionyl-CoA carboxylase deficiency.

4. Hyperglycinemia (secondary): The elevated glycine could be a consequence of the underlying metabolic derangement rather than primary non-ketotic hyperglycinemia, as the latter typically presents with severe encephalopathy without significant systemic manifestations.

5. Multiple carboxylase deficiency (e.g., biotinidase deficiency, holocarboxylase synthetase deficiency): These disorders can cause deficiencies of multiple biotin-dependent carboxylases, including pyruvate carboxylase and propionyl-CoA carboxylase. However, the degree of lethality and hyperammonemia would be unusual, and additional carboxylase deficiencies would be expected.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: This X-linked urea cycle disorder fits well with the patient's hyperammonemia, oroticaciduria, neurological symptoms (lethargy, ataxia, vomiting), and risk of death in adolescence if untreated. The lack of respiratory alkalosis is also consistent.

2. Carbamoyl phosphate synthetase I (CPS1) deficiency: Another urea cycle disorder that could explain the patient's presentation. Key symptoms not mentioned that can occur with CPS1 deficiency include seizures and coma.

3. Citrullinemia type I: A third urea cycle disorder in the differential given the patient's symptoms. Additional features not reported here can include growth restriction and intellectual disability.

4. Argininosuccinic aciduria: A urea cycle disorder that causes hyperammonemia, neurological symptoms, and high risk of death without treatment. Patients may also have hepatomegaly and trichorrhexis nodosa (coarse/fragile hair), which were not mentioned.

5. HHH syndrome (hyperornithinemia-hyperammonemia-homocitrullinuria): A rarer urea cycle-related disorder that matches the patient's hyperammonemia and neurological symptoms. Patients typically also have intermittent episodes of vomiting, confusion, and coma, as well as growth deficits and intellectual disability.",Hereditary metabolic disorders
[],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with vomiting, hypoglycemia (implied by timing of death), ethylmalonic aciduria, and decreased acyl-CoA dehydrogenase activity. May also have hyperammonemia and liver dysfunction.

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Matches the decreased 3-hydroxyacyl-CoA dehydrogenase level, ethylmalonic aciduria, and early death. Other symptoms may include hypoglycemia, cardiomyopathy, and retinopathy.

3. Glutaric acidemia type 2: Also causes ethylmalonic aciduria, low carnitine, and decreased acyl-CoA dehydrogenase activities. Can present with hypoglycemia, metabolic acidosis, cardiomyopathy, and early death.

4. Propionic acidemia: May have vomiting, lethargy progressing to coma, cardiomyopathy, and early death. Would expect to see propionylcarnitine on acylcarnitine profile and methylcitrate in urine.

5. Carnitine-acylcarnitine translocase deficiency: Impairs carnitine shuttle and fatty acid oxidation, causing low free carnitine, high acylcarnitines, hypoglycemia, hyperammonemia, and early death. Ethylmalonic aciduria may be less prominent than in other fatty acid oxidation disorders.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome (SLOS): Consistent with patient's dysmorphic features, intellectual disability, elevated 7-dehydrocholesterol, and severe disease course. May also have 2-3 toe syndactyly and genital anomalies (not reported).

2. Noonan syndrome: Some overlapping features like ptosis, low-set ears, short stature, and developmental delay. However, lacks characteristic heart defects and does not explain the cholesterol abnormalities.

3. Cornelia de Lange syndrome: Similar dysmorphic facial features, growth restriction, and intellectual disability. However, usually has smaller head size, hirsutism, and limb reduction defects (not reported). Biochemical profile is not consistent.

4. Desmosterolosis: Rare disorder of cholesterol synthesis that can cause similar dysmorphic features, intellectual disability, and failure to thrive. Would have elevated desmosterol levels rather than 7-dehydrocholesterol.

5. Lathosterolosis: Another rare cholesterol biosynthesis disorder with overlapping features to SLOS. Key difference is an elevation of lathosterol rather than 7-dehydrocholesterol.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: Characterized by intellectual disability, ataxia, tremor, and the pathognomonic finding of elevated L-2-hydroxyglutaric acid. The cerebral atrophy and basal ganglia abnormalities are consistent. Can be associated with neonatal and childhood death in severe cases.

2. Canavan disease: Rare genetic leukodystrophy that can present with intellectual disability, ataxia, and cerebral atrophy. However, L-2-hydroxyglutaric aciduria would not be expected.

3. Glutaric aciduria type 1: Inherited metabolic disorder that can cause intellectual disability, ataxia, and basal ganglia abnormalities. Usually also associated with macrocephaly and episodes of metabolic decompensation. Elevated glutaric acid rather than L-2-hydroxyglutaric acid would be seen.

4. Mitochondrial disorder: Certain mitochondrial disorders such as PDH deficiency can cause intellectual disability, ataxia, and brain abnormalities. Additional symptoms such as epilepsy, muscle weakness, and elevated lactate are often seen.

5. Infantile neuroaxonal dystrophy: Rare inherited disorder that can present with intellectual disability, ataxia, and cerebral atrophy. Onset is usually in infancy or early childhood. Does not cause L-2-hydroxyglutaric aciduria.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Consistent with metabolic acidosis, hypotonia, seizures, and early mortality. 3-methylglutaconic aciduria can be seen. Additional symptoms may include vomiting, lethargy, and coma.

2. Methylmalonic acidemia: Presents similarly to propionic acidemia with metabolic acidosis, seizures, hypotonia, and high mortality. Methylmalonic acid would be elevated in urine.

3. Glutaric acidemia type 1: Characterized by metabolic acidosis, dicarboxylic aciduria, hypotonia, and dystonic posturing like opisthotonus. Macrocephaly is common but not reported here.

4. Canavan disease: A leukodystrophy causing progressive hypotonia, seizures, and early death. Macrocephaly and optic atrophy are often seen. Urine organic acids may show elevated N-acetylaspartic acid.

5. Leigh syndrome: A mitochondrial disorder with hypotonia, seizures, and regression, often with basal ganglia changes on brain MRI. Lactic acidosis and specific respiratory chain enzyme defects are characteristic.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. Nonketotic hyperglycinemia: Presents with seizures, developmental delay, and early death. The skin findings and metabolic abnormalities could be secondary features.

2. Menkes disease: An inherited disorder of copper metabolism causing seizures, abnormal hair, failure to thrive, and early death. May have skin abnormalities but usually not the primary feature.  

3. Mitochondrial disorder: Can cause seizures, developmental regression, failure to thrive, and metabolic abnormalities. Skin and hair changes sometimes seen.

4. Gaucher disease type 2: Severe form with seizures, abnormal eye movements, spasticity, and death in infancy. Skin findings not typical.

5. Epidermolysis bullosa: Group of genetic skin disorders with severe blistering and skin erosions. Can be associated with other organ system involvement and early death in severe cases. Seizures and metabolic abnormalities would be atypical.",Hereditary metabolic disorders
['X-linked hypophosphatemia'],"1. Hypophosphatemic rickets: Characterized by low phosphate levels, skeletal abnormalities, and elevated alkaline phosphatase. Other symptoms like nephritis are less typical.

2. Renal osteodystrophy: A disorder of bone metabolism due to chronic kidney disease. Consistent with nephritis, hypophosphatemia, and skeletal changes. Endocrine abnormalities are possible but less common.

3. Fanconi syndrome: A disorder of the kidney tubules that can lead to loss of phosphate and other minerals, rickets-like bone changes, and sometimes nephritis. Matches many of the patient's symptoms.

4. Hyperparathyroidism: Overactivity of the parathyroid glands, leading to high calcium, low phosphate, kidney dysfunction, and skeletal changes. Elevated alkaline phosphatase is common. Infant/childhood death would be atypical.

5. Dent disease: A rare genetic disorder of the kidneys that causes mineral loss, kidney dysfunction, and rickets-like bone changes. Can be associated with infant/childhood mortality in severe cases. Endocrine abnormalities are not usually seen.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Nonketotic hyperglycinemia (NKH): Elevated glycine levels in blood and urine, along with hyperammonemia, leukopenia, and early mortality, fit this glycine metabolism disorder. Speech delay and seizures are common neurological sequelae. Skin rash is not typical.

2. Propionic acidemia (PA) or methylmalonic acidemia (MMA): These organic acidemias cause elevated glycine, hyperammonemia, leukopenia, skin rash, and multi-organ dysfunction. Cardiomyopathy and pancytopenia are often seen but were not reported here.

3. 3-Phosphoglycerate dehydrogenase deficiency (3-PGDH): Fits the patient's serine deficiency, elevated glycine, speech delay, and skin rash. However, hyperammonemia and early mortality are atypical, and seizures are a key feature not reported.

4. Urea cycle disorders (e.g., CPS1, OTC, ASS1, ASL deficiency): The hyperammonemia, leukopenia, and early mortality are consistent, but the amino acid abnormalities and skin rash point away from these conditions. Respiratory alkalosis is often seen but was not mentioned.

5. Mitochondrial disorders (e.g., POLG-related disorders): Can explain developmental delays, liver dysfunction, leukopenia, and early mortality. Specific findings like elevated lactate, myopathy, or diabetes are missing but would support this category of diseases.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","1. Methylmalonic acidemia with homocystinuria, cblC type: Characterized by methylmalonic aciduria, hyperhomocystinemia, neurologic dysfunction, and early mortality. Key symptoms not reported include microcephaly, hydrocephalus, and retinopathy.

2. Isolated methylmalonic acidemia, mut0 type: Presents with severe methylmalonic aciduria, metabolic ketoacidosis, hyperammonemia, hypotonia, and failure to thrive in early infancy. Homocystinuria and abnormal cerebral white matter would be atypical.

3. Propionic acidemia: Another organic acidemia that can present with hypotonia, developmental delay, gastrointestinal symptoms, and early mortality. Methylmalonic aciduria and homocystinuria are not typical features.

4. Glutaric acidemia type 1: Can cause hypotonia, developmental delay, and abnormal cerebral white matter. Methylmalonic aciduria and homocystinuria would not be expected. Characteristic finding of fronto-temporal atrophy was not described.

5. Multiple carboxylase deficiency (biotinidase deficiency or holocarboxylase synthetase deficiency): Can present with hypotonia, developmental delay, and metabolic acidosis. Methylmalonic aciduria may be present but homocystinuria and abnormal white matter would be unusual. Characteristic skin rash was not reported.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Disorder of fatty acid oxidation that can present with neonatal death. Elevated urinary medium-chain dicarboxylic acids would be expected.

2. Propionic acidemia: Organic acid disorder that often presents in the neonatal period with poor feeding, lethargy, and metabolic acidosis progressing to death if untreated. Elevated urinary methylcitrate and 3-hydroxypropionate would be characteristic.

3. Methylmalonic acidemia: Another organic acidemia with potential for neonatal presentation and death. Elevated urinary methylmalonic acid is the key diagnostic finding.

4. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Severe neonatal-onset form can result in cardiomyopathy, arrhythmia, and sudden death. Elevated urinary long-chain dicarboxylic acids would be seen.

5. Glutaric acidemia type II: Multiple acyl-CoA dehydrogenase deficiency affecting fatty acid and amino acid metabolism. Neonatal form is usually fatal. Characteristic urinary organic acids include glutaric, ethylmalonic, 3-hydroxyisovaleric, and isovalerylglycine.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Urea cycle disorder: Presents with hyperammonemia, lethargy, hypotonia, and can be life-threatening in infancy if untreated. Spasticity and hyperreflexia are atypical but can occur in advanced stages.

2. Nonketotic hyperglycinemia: Causes lethargy, hypotonia, feeding problems, and frequent hiccups/apnea in infants. Can progress to intractable seizures, spasticity, and respiratory failure leading to death. 

3. Maple syrup urine disease: Infants present with poor feeding, lethargy, hypotonia, and a distinctive sweet odor to urine and cerumen. Can rapidly progress to seizures, coma, and central respiratory failure if untreated.

4. Zellweger syndrome (cerebrohepatorenal syndrome): Severe hypotonia, seizures, and distinctive facial features. Enlarged liver, renal cysts, and bony stippling also occur. Most do not survive past 1 year.

5. Infantile neuronal ceroid lipofuscinosis (INCL): Presents with hypotonia, developmental regression, and myoclonic jerks. Visual impairment and seizures progress to a vegetative state. Juvenile and adult onset forms exist but infantile type is most severe.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Hallmark symptoms of death in infancy/childhood, metabolic acidosis, and diagnostic finding of decreased methylmalonyl-CoA mutase activity. Other typical symptoms that were not reported include poor feeding, vomiting, lethargy, and developmental delay.

2. Propionic acidemia: Can also present with death in infancy, metabolic acidosis, and potentially decreased methylmalonyl-CoA mutase activity. However, methylmalonic acidemia is more likely given the specific enzyme deficiency noted.

3. Disorders of cobalamin metabolism (e.g. cblA, cblB, cblC, cblD): Defects in cobalamin (vitamin B12) metabolism can impair methylmalonyl-CoA mutase activity and cause a similar clinical picture as methylmalonic acidemia. Additional findings may include megaloblastic anemia, hyperhomocysteinemia, and methylmalonic aciduria.

4. MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes): This mitochondrial disorder can present in childhood with metabolic acidosis and early death, but would typically have additional neurologic symptoms like seizures, stroke-like episodes, and muscle weakness. Methylmalonic acidemia is much more likely in this case.

5. Pyruvate dehydrogenase deficiency: Another metabolic disorder that can present with lactic acidosis and early childhood death. However, patients typically have severe neurologic dysfunction, seizures, and structural brain abnormalities. Less likely than methylmalonic acidemia given this patient's presentation and diagnostic studies.",Hereditary metabolic disorders
[],"1. Propionic acidemia: Consistent with hyperactivity, spasticity, hemolytic anemia, metabolic acidosis, and early death. May also cause ketoacidosis and hyperammonemia.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia with neurological symptoms, metabolic acidosis, and risk of infant death. May also have neutropenia and pancytopenia.

3. Mitochondrial disorder (e.g. Leigh syndrome): Can explain neurological symptoms, metabolic acidosis, hemolytic anemia, and early mortality. Other symptoms may include cardiomyopathy, liver dysfunction, and lactic acidosis.  

4. Zellweger spectrum disorder: Matches hyperactivity, spasticity, liver dysfunction (hyperbilirubinemia), and early death. May also present with dysmorphic features, seizures, and hearing/vision impairment.

5. Severe combined immunodeficiency (SCID): The recurrent viral infections and early mortality are consistent with SCID. However, it would not typically cause the metabolic and neurological symptoms reported.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"1. Citrullinemia type I: Elevated plasma citrulline, hyperammonemia, respiratory distress, and neonatal death are consistent with this urea cycle disorder caused by argininosuccinate synthetase deficiency. May also have seizures and coma.

2. Argininosuccinic aciduria: Another urea cycle disorder with elevated citrulline that could explain the patient's hyperammonemia, respiratory issues, and neonatal death. Caused by argininosuccinate lyase deficiency. Additional symptoms may include hepatomegaly and brittle hair.

3. Carbamoyl phosphate synthetase I deficiency: A severe urea cycle disorder that typically presents in the neonatal period with hyperammonemia, lethargy, poor feeding, and death without prompt treatment. Does not cause elevated citrulline.

4. Transient hyperammonemia of the newborn: A temporary metabolic disturbance in neonates that causes hyperammonemia, respiratory alkalosis, and irritability. Symptoms resolve within a few days. Less likely given this patient's death and elevated citrulline.

5. Pyruvate dehydrogenase deficiency: A rare metabolic disorder that can present in infancy with hypotonia, lethargy, respiratory distress, and lactic acidosis. Can be fatal. Elevated citrulline would be atypical.",Hereditary metabolic disorders
[],"1. Methylmalonic acidemia: Characterized by neurological abnormalities, metabolic acidosis, hyperammonemia, hyperglycinemia, methylmalonic aciduria, and decreased methylmalonyl-CoA mutase activity. Can lead to intellectual disability, seizures, coma, kidney failure, and early death if untreated.

2. Propionic acidemia: Another organic acidemia that can present similarly to methylmalonic acidemia, with poor feeding, vomiting, lethargy, intellectual disability, seizures, and hyperammonemia. Methylcitrate is often elevated rather than methylmalonic acid.

3. Urea cycle disorder: The hyperammonemia, altered mental status, seizures, and early death fit with a urea cycle defect leading to toxic ammonia levels. However, the patient's other metabolic abnormalities are less typical.

4. MSUD (maple syrup urine disease): Can cause poor feeding, vomiting, lethargy, intellectual disability, seizures, brain edema, and a characteristic maple syrup odor. Branched-chain amino acids and keto-acids are elevated. Some features fit but others are less consistent.

5. Mitochondrial disorder: The combination of neurological, kidney, hematologic and metabolic abnormalities could fit with a mitochondrial disorder affecting energy production. However, the specific metabolic derangements seen are less common.",Hereditary metabolic disorders
['Dihydropteridine reductase deficiency'],"1. Menkes disease: Explains the patient's neurological symptoms (seizures, hypotonia, developmental delay), abnormal hair (alopecia), and shortened lifespan. Key features not reported include hypopigmented or kinky hair and cutis laxa.

2. Zellweger syndrome: Accounts for the microcephaly, seizures, hypotonia, intellectual disability, and early death. May also explain the nystagmus and abnormal brain imaging. Hepatomegaly and distinctive facial features are not mentioned but would support this diagnosis.

3. Phenylketonuria (PKU): The hyperphenylalaninemia fits with PKU, which can cause microcephaly, intellectual disability, seizures, and cerebral white matter abnormalities if untreated. However, PKU does not typically cause nystagmus, alopecia, or death in infancy/childhood.

4. Maple syrup urine disease (MSUD): The patient's neurological symptoms and intellectual disability could be explained by MSUD, which can present in infancy with poor feeding, lethargy, hypotonia, and seizures. The disease can be fatal if untreated. However, the patient's hypertyrosinemia and hyperphenylalaninemia are less consistent with MSUD.

5. Niemann-Pick disease type A: Could explain the psychomotor delay, hypotonia, and early death. Neurodegenerative changes on brain imaging would be expected. The patient's alopecia and nystagmus are atypical for Niemann-Pick. Hepatosplenomegaly and cherry-red spot are not reported here but are key features.",Hereditary metabolic disorders
[],"1. Mitochondrial DNA depletion syndrome: Consistent with the patient's cytochrome C oxidase-negative muscle fibers, feeding difficulties, and death in infancy. Other features like the skin rash and metabolic abnormalities could also fit. Key features not reported include liver dysfunction and neurological abnormalities.

2. Ethylmalonic encephalopathy: The patient's ethylmalonic aciduria, skin lesions, and gastrointestinal symptoms fit with this diagnosis. Cytochrome C oxidase dysfunction can also be seen. However, neurological symptoms and developmental delay were not mentioned.

3. Glutaric acidemia type II: Could explain the patient's ethylmalonic aciduria, glycine abnormality, feeding issues, and early death. Skin findings are not typical of this condition. Hypoglycemia and metabolic acidosis were also not reported.

4. Propionic acidemia: The feeding difficulties, glycine abnormality, and early death fit this diagnosis. Skin lesions are not a classic feature. Other common symptoms not mentioned include lethargy, hypotonia, and developmental delay.  

5. Methylmalonic acidemia: Similar to propionic acidemia, this could cause the feeding issues, metabolic changes, and early death seen in this patient. Skin findings would be unusual. Neurological symptoms and metabolic acidosis are often seen but were not reported.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Arginase deficiency: Hyperammonemia, low plasma citrulline, hypoargininemia, oroticaciduria, seizures, cerebral edema, cyanosis, neonatal/infant death. Key feature not reported: Spasticity.

2. Carbamoyl phosphate synthetase I deficiency: Hyperammonemia, low citrulline, seizures, cerebral edema, cyanosis, neonatal/infant death. Key features not reported: Respiratory alkalosis, no oroticaciduria.

3. Ornithine transcarbamylase deficiency: Hyperammonemia, low citrulline, seizures, cerebral edema, cyanosis, neonatal/infant death (in males). Key features not reported: Orotic aciduria, normal arginine.

4. Propionic acidemia: Hyperammonemia, seizures, cerebral edema, cyanosis, infant death. Key features not reported: Metabolic acidosis, ketonuria, hypoglycemia.

5. Carnitine deficiency: Hyperammonemia, seizures, cerebral edema, cyanosis, infant death. Key features not reported: Hypoketotic hypoglycemia, hepatomegaly, cardiomyopathy.",Hereditary metabolic disorders
['Canavan disease'],"1. Nonketotic hyperglycinemia: Consistent with seizures, hyperammonemia, abnormal glycine levels. Can cause early infantile death. Skin rash not typically reported.

2. Maple syrup urine disease: Matches hyperammonemia, seizures, abnormal amino acid levels (leucine, isoleucine, valine), and can be fatal in infancy if untreated. Additional symptoms may include poor feeding, lethargy, and urine with a maple syrup odor.

3. Urea cycle disorders (e.g., ornithine transcarbamylase deficiency): Cause hyperammonemia, seizures, and can lead to neonatal death. Aminoaciduria and abnormal amino acid levels may be seen. Skin rash is not a classic feature.

4. Glutaric aciduria type 1: Associated with seizures, hyperammonemia, and can cause death in infancy. Aminoaciduria and abnormal amino acid levels are consistent. Typical symptoms not reported include macrocephaly and dystonia.

5. Neonatal lupus erythematosus: The erythematous rash could fit this autoimmune disorder. It can cause seizures and has a high mortality rate. However, hyperammonemia and abnormal amino acid levels are not typical features.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Seizures, opisthotonus, respiratory insufficiency, feeding difficulties, neonatal presentation, and elevated branched-chain amino acids (hypervalinemia, hyperleucinemia, hyperisoleucinemia) are all consistent with this diagnosis. The characteristic maple syrup odor of the urine was not mentioned but is often present.

2. Sepsis: Feeding difficulties, respiratory insufficiency, and death in infancy could fit with overwhelming sepsis in a neonate, though this would not directly explain the seizures, opisthotonus, or elevated BCAAs.

3. Organic acidemia (e.g. propionic acidemia, methylmalonic acidemia): Can present in the neonatal period with poor feeding, lethargy, seizures, metabolic acidosis, and high ammonia levels. Elevated BCAAs would be atypical.

4. Urea cycle disorder (e.g. ornithine transcarbamylase deficiency): Another group of metabolic disorders that can present in a neonate with lethargy, respiratory distress, seizures, and hyperammonemia. Elevated BCAAs are not characteristic.

5. Meningitis: Bacterial meningitis in a neonate can present with lethargy, poor feeding, respiratory distress, seizures, and opisthotonus. However, the metabolic abnormalities seen in this patient are not typical for meningitis alone.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased 3-hydroxyacyl-CoA dehydrogenase, episodes of hypoglycemia and metabolic crisis, sudden infant death. Does not typically cause congenital abnormalities.

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Matches decreased enzyme activity, early-onset cardiomyopathy, hypoglycemia, liver disease, and risk of sudden death. Congenital anomalies are not usually seen.

3. Carnitine palmitoyltransferase II (CPT2) deficiency: Aligns with abnormal carnitine levels, episodes of rhabdomyolysis and liver disease, risk of infant death. Congenital abnormalities are not typical.

4. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Fits with early-onset cardiomyopathy, hypoglycemia, liver disease, and sudden death risk. Prenatal abnormalities are not characteristic.

5. Glutaric acidemia type II: Consistent with congenital anomalies, hypoglycemia, cardiomyopathy, and early mortality. Multiple acyl-CoA dehydrogenase deficiencies cause a more severe presentation compared to the isolated enzyme defects above.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Intellectual disability, seizures, hyperphenylalaninemia. PKU does not typically cause white matter changes or high mortality.

2. Tyrosinemia type I: Intellectual disability, seizures, hypertyrosinemia, high mortality rate. However, this usually also causes liver and kidney dysfunction.

3. Krabbe disease (globoid cell leukodystrophy): Intellectual disability, motor delay, seizures, abnormal white matter, high mortality rate. Key features also include vision loss and peripheral neuropathy.

4. Canavan disease: Intellectual disability, motor delay, seizures, abnormal white matter, high mortality rate. Macrocephaly is also a key feature not reported here.

5. Multiple carboxylase deficiency (biotinidase deficiency): Intellectual disability, seizures, motor delay, high mortality rate. Hearing loss, skin rash, and alopecia are other features not mentioned here.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson disease: characterized by low ceruloplasmin and copper levels in blood, high urine copper, copper accumulation in liver leading to hepatomegaly and liver dysfunction (elevated transaminases). Can also cause neurologic symptoms like hypotonia. Usually presents in childhood or adolescence and can be fatal if untreated.

2. Niemann-Pick disease type C: a lipid storage disorder that can cause hepatosplenomegaly, liver dysfunction, hypotonia, and early death. Does not typically involve copper metabolism abnormalities.

3. Gaucher disease: a lysosomal storage disorder causing hepatosplenomegaly, liver dysfunction, hypotonia, and bone abnormalities. Also does not usually affect copper.

4. Tyrosinemia type 1: an amino acid disorder causing liver failure, kidney dysfunction, hypotonia, and early death if untreated. Elevated blood tyrosine and methionine levels are key features not reported here.

5. Mitochondrial hepatopathy: a group of genetic disorders causing liver dysfunction, hypotonia, and neurologic symptoms due to impaired mitochondrial energy production. Copper abnormalities would be atypical.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by cerebellar vermis hypoplasia, intellectual disability, hypotonia, ataxia, and abnormal eye movements. Key feature not reported is ""molar tooth sign"" on brain MRI.

2. Pontocerebellar hypoplasia (PCH): Autosomal recessive disorder causing cerebellar and pontine hypoplasia/atrophy, severe psychomotor delay, visual impairment, and early death. Strabismus and craniofacial dysmorphism can be seen.

3. Walker-Warburg syndrome: Severe disorder featuring cerebellar malformation, lissencephaly, intellectual disability, hypotonia, eye anomalies, and death usually within first 3 years of life. Hydrocephalus and seizures are common features not mentioned.

4. Congenital disorder of glycosylation (CDG): Group of metabolic disorders that can manifest with cerebellar hypoplasia, severe developmental delay, hypotonia, ataxia, and dysmorphic features. Failure to thrive and multiple organ dysfunction are often present.

5. Dandy-Walker malformation: Characterized by cerebellar vermis hypoplasia, intellectual disability, hypotonia, ataxia, and often hydrocephalus and seizures. Strabismus can occur but craniofacial malformations are less common than in other disorders listed.",Hereditary metabolic disorders
['Phenylketonuria'],"1: Tyrosinemia type I: Abnormality of prenatal development, neonatal death, hypertyrosinemia, and hyperphenylalaninemia are consistent. May also have liver failure and renal tubular dysfunction.

2: Maple syrup urine disease: Neonatal death, abnormal prenatal development, and hyperphenylalaninemia fit. Usually also have poor feeding, lethargy, seizures, and maple syrup odor to urine.

3: Phenylketonuria (PKU): Hyperphenylalaninemia and abnormal development are consistent, but classic PKU is not typically fatal in infancy/childhood. Severe forms could potentially explain the early deaths.

4: Zellweger syndrome: Abnormality of prenatal development and neonatal/infant death fit this peroxisomal biogenesis disorder. May also have hypotonia, seizures, and liver dysfunction. Hypertyrosinemia and hyperphenylalaninemia are not typical.

5: Glutaric acidemia type I: Can cause prenatal abnormalities and infant death. Characteristic fronto-temporal atrophy, macrocephaly, and dystonia/dyskinesia. Hypertyrosinemia and hyperphenylalaninemia are not usually seen.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Macrocephaly, hypotonia, cerebral atrophy, early death, glutaric aciduria, abnormal lysine. Key symptom not reported: dystonia.

2. Pyruvate dehydrogenase deficiency: Hypotonia, cerebral abnormalities, lactic acidosis, early death. Symptoms not reported: seizures, microcephaly (though macrocephaly can occur).

3. D-2-hydroxyglutaric aciduria: Macrocephaly, hypotonia, cerebral abnormalities, lactic acidosis, early death. Additional finding not reported: seizures.

4. Canavan disease: Macrocephaly, hypotonia, lactic acidosis, cerebral degeneration, early death. Symptom not reported: optic atrophy.

5. Molybdenum cofactor deficiency: Hypotonia, cerebral abnormalities, lactic acidosis, early death. Symptoms not reported: seizures, lens dislocation. Glutaric aciduria and hypercalcemia are atypical.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this condition can cause failure to thrive and death in infancy or childhood if untreated. Other features like liver failure and renal tubular dysfunction are not mentioned.

2. Phenylketonuria (PKU): The patient's hyperphenylalaninemia is consistent with PKU, an inborn error of phenylalanine metabolism. However, PKU is usually not fatal in infancy if treated with a low-phenylalanine diet. Intellectual disability is a key feature not reported.

3. Maple syrup urine disease (MSUD): Another inborn error of amino acid metabolism that can be fatal in infancy, but the patient's high tyrosine and phenylalanine are not typical of MSUD. Features of MSUD like feeding difficulties, lethargy, and maple syrup odor of urine are not mentioned.

4. Zellweger spectrum disorder: This peroxisomal biogenesis disorder causes abnormal prenatal development, hypotonia, and early death. However, the patient's amino acid abnormalities are not characteristic of Zellweger syndrome.

5. Trisomy 13: This chromosomal disorder is characterized by abnormal prenatal development and multiple congenital anomalies. It is often fatal in infancy. However, the patient's hypertyrosinemia and hyperphenylalaninemia are not typical features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Zellweger syndrome: Severe neonatal presentation with growth restriction, microcephaly, effusions, feeding problems, and early death. Caused by a peroxisome biogenesis disorder. Patient's hypertyrosinemia also fits, but characteristic facial features and liver dysfunction are not mentioned.

2. Trisomy 18 (Edwards syndrome): Can cause prenatal growth restriction, microcephaly, short stature, feeding problems, and high infant mortality. Other common features like clenched fists, rocker-bottom feet, and heart defects are not noted.

3. Pyruvate dehydrogenase deficiency: Severe neonatal form can present with microcephaly, growth retardation, brain malformations, lactic acidosis, and early death. Explanation for patient's effusions and amino acid abnormalities is lacking.

4. Nonketotic hyperglycinemia: Neonatal form characterized by microcephaly, hypotonia, feeding difficulties, and early death. Seizures and respiratory problems are common but not reported here. Patient's effusions and short stature are atypical.

5. Congenital disorder of glycosylation type Ia: Can feature microcephaly, growth failure, failure to thrive, and infant death. Inverted nipples, abnormal fat pads, and liver dysfunction are not mentioned. Unclear if accounts for patient's amino acid issues.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: The most common urea cycle disorder. Consistent with hyperammonemia, vomiting, hyperglutaminemia, and oroticaciduria. Can be severe and lead to death in childhood if untreated.

2. Carbamoyl phosphate synthetase I (CPS1) deficiency: Another urea cycle disorder that fits the patient's presentation. Typically presents in the neonatal period with hyperammonemia, vomiting, lethargy progressing to coma, and death if untreated. Oroticaciduria may be less prominent than in OTC deficiency.

3. Citrullinemia type I (argininosuccinate synthetase deficiency): Urea cycle disorder characterized by hyperammonemia, vomiting, hyperglutaminemia, and increased citrulline levels. Oroticaciduria is not a typical finding.

4. Argininosuccinic aciduria (argininosuccinate lyase deficiency): Urea cycle disorder with hyperammonemia, vomiting, and increased argininosuccinic acid in blood and urine. Oroticaciduria is not typically seen.

5. Transient hyperammonemia of the newborn: A non-genetic condition that can cause vomiting and hyperammonemia in neonates, but is usually self-limited. Hyperglutaminemia and oroticaciduria would be less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Abnormality of prenatal development, hyperphenylalaninemia, and risk of intellectual disability if untreated. Can be fatal if severe and undiagnosed.

2. Tyrosinemia type I: Abnormal tyrosine levels, risk of liver failure, kidney dysfunction, and peripheral neuropathy. Can cause death in infancy or early childhood if untreated.  

3. Maple syrup urine disease: Neonatal onset, poor feeding, lethargy, and a maple syrup odor to urine and sweat. Risk of seizures, coma, and death if untreated. Abnormal levels of branched-chain amino acids.

4. Propionic acidemia: Elevated urinary carboxylic acids, risk of metabolic acidosis, hyperammonemia, and death in infancy. Can also cause developmental delays and cardiomyopathy.

5. Methylmalonic acidemia: Elevated urinary carboxylic acids, metabolic acidosis, hyperammonemia, and risk of infant death, similar to propionic acidemia. Can also cause developmental delays, seizures, and kidney failure.",Hereditary metabolic disorders
['Pearson syndrome'],"1. Methylmalonic acidemia: Consistent with kidney dysfunction, pancreatic insufficiency, hypotonia, lethargy, metabolic abnormalities, and early mortality. Additional symptoms may include intellectual disability and seizures.

2. Propionic acidemia: Matches the patient's kidney issues, hypotonia, lethargy, metabolic changes, feeding problems, and risk of early death. May also present with cardiomyopathy and movement disorders.

3. Mitochondrial DNA depletion syndrome: Explains the multi-organ involvement (kidney, liver, heart, pancreas), hypotonia, feeding issues, and childhood mortality. Other features can include hearing loss and intestinal dysmotility.

4. Carnitine palmitoyltransferase II deficiency: The decreased plasma carnitine, kidney dysfunction, hypoglycemia, and muscle weakness fit this diagnosis. Rhabdomyolysis and liver disease may also occur.

5. Pearson syndrome: A mitochondrial disorder characterized by exocrine pancreatic dysfunction, kidney failure, metabolic acidosis, and cytopenias, all seen in this patient. Hearing loss and ptosis are additional possible features.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Consistent with facial dysmorphism, syndactyly, hypotonia, feeding difficulties, and elevated 7-dehydrocholesterol. This disorder of cholesterol synthesis can be life-threatening in severe cases.

2. Congenital disorders of glycosylation: Some forms can present with facial dysmorphism, hypotonia, feeding problems, and early death. However, the patient's cholesterol abnormalities are not typical.

3. Zellweger spectrum disorders: Facial dysmorphism, hypotonia, and early death can occur. Additional symptoms may include eye abnormalities, liver dysfunction, and hearing loss, which were not reported in this patient.

4. Inborn errors of bile acid synthesis: Can cause cholesterol abnormalities, hypotonia, feeding difficulties, and progressive liver disease leading to early death. Facial features are not a prominent sign.

5. Chromosomal disorders (e.g., trisomies): Many are associated with facial dysmorphism, hypotonia, feeding difficulties, and potentially life-threatening complications. The cholesterol abnormalities would be atypical.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"1. Severe combined immunodeficiency (SCID): Recurrent infections, failure to thrive, early death. Missing symptom: chronic diarrhea.

2. Familial Mediterranean fever: Recurrent abdominal pain, vomiting, childhood onset. Missing symptoms: Fever, joint pain.

3. Intestinal malrotation with volvulus: Abdominal pain, vomiting, potential for ischemic bowel and death if untreated in an infant. Missing symptom: Abdominal distension.

4. Leukemia: Recurrent infections due to immunosuppression, abdominal pain, risk of childhood death. Missing symptoms: Easy bruising/bleeding, fatigue.

5. Hirschsprung disease: Vomiting, abdominal pain, potential for enterocolitis and death if untreated in an infant. Missing symptom: Constipation.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Argininosuccinic aciduria: Characterized by argininuria, elevated plasma citrulline, hyperammonemia, and metabolic acidosis. Can lead to neonatal death if untreated.

2. Citrullinemia type I: Presents with hyperammonemia, metabolic acidosis, elevated plasma citrulline, and early infant death. Argininuria and hyperglycinuria are not typically seen.

3. Ornithine transcarbamylase (OTC) deficiency: An X-linked urea cycle disorder causing hyperammonemia and metabolic acidosis. Argininuria is not usually present. More common in males, with neonatal onset in severe cases.

4. Carbamoyl phosphate synthetase I (CPS1) deficiency: Leads to hyperammonemia and metabolic acidosis but normal plasma citrulline. Onset is typically in the neonatal period with poor feeding, lethargy, and seizures.

5. Propionic acidemia: An organic acidemia that can cause metabolic acidosis, hyperammonemia, hyperglycinuria and hyperglutaminemia. Argininuria and elevated citrulline are not characteristic. Presents in infancy with feeding problems, lethargy and developmental delay.",Hereditary metabolic disorders
[],"1. Methylmalonic acidemia: Patient has classic symptoms including neurological deterioration, lethargy, hypotonia, and failure to thrive in infancy, along with diagnostic finding of elevated methylmalonic acid. Decreased plasma carnitine also often seen.

2. Propionic acidemia: Can cause similar presentation to methylmalonic acidemia with lethargy, hypotonia, poor feeding, and hyperammonemia. However, methylmalonic acid is not typically elevated.

3. Urea cycle defect: Hyperammonemia and neurological symptoms fit, but additional findings like respiratory alkalosis and orotic aciduria would be expected. Methylmalonic acidemia and aciduria not typical. 

4. Homocystinuria: Elevated homocysteine fits, but patient would also be expected to have lens dislocation, marfanoid habitus, and thromboembolic events. Methylmalonic acid findings not explained.

5. Multiple carboxylase deficiency: Can cause neurological deterioration, hypotonia, and methylmalonic aciduria. However, additional findings like skin rash and alopecia would be expected, and degree of methylmalonic acidemia is usually milder than in isolated methylmalonic acidemia.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with hyperammonemia, abnormal amino acids, hypotonia, and early death. May also have ketoacidosis, neutropenia.

2. Methylmalonic acidemia: Also features hyperammonemia, metabolic acidosis, hypotonia, lethargy progressing to coma, and early death.  

3. Carnitine uptake defect (primary carnitine deficiency): Matches the low plasma carnitine. Can present with hypotonia, hyperammonemia, cardiomyopathy and early death.

4. Urea cycle disorders (e.g. CPS1 deficiency, OTC deficiency): The hyperammonemia and premature birth fit, but no mention of respiratory alkalosis or orotic aciduria which are common.

5. Glutaric acidemia type 2: Multiple acyl-CoA dehydrogenase deficiency causing acidosis, hypoglycemia, hyperammonemia, hypotonia, cardiomyopathy. Usually fatal in infancy.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Trisomy 18 (Edwards syndrome): Abnormality of prenatal development, high infant mortality rate, upper airway obstruction. Other features not mentioned include congenital heart defects, clenched hands, and rocker-bottom feet.

2. Tyrosinemia type I: Hypertyrosinemia, risk of neonatal death if untreated. Additional symptoms may include liver failure, renal tubular dysfunction, and neurological crises.

3. Phenylketonuria (PKU): Hyperphenylalaninemia, can lead to severe intellectual disability and neurological issues if untreated. Screening allows for early diagnosis and dietary management.

4. Congenital central hypoventilation syndrome (CCHS): Upper airway obstruction, chronic pulmonary issues. Caused by mutations affecting autonomic control of breathing. Can be associated with Hirschsprung disease and tumors of neural crest origin.

5. Zellweger spectrum disorders: Abnormality of prenatal development, neonatal complications, risk of infant death. Caused by peroxisomal biogenesis disorders. Can present with dysmorphic features, hypotonia, seizures, and liver dysfunction.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased free carnitine, 3-hydroxyacyl-CoA dehydrogenase, hypoxemia, and death in infancy/childhood. May not explain the spasticity and ileus.

2. Propionic acidemia: Can present with spasticity, ileus, premature birth, neonatal death, and decreased carnitine levels. Vitamin B12 abnormalities may be seen. Ferritin and peritoneal effusion less common.

3. Zellweger spectrum disorder: Matches the spasticity, ileus, premature birth, neonatal death, hypoxemia, and effusions. May have secondary carnitine and vitamin deficiencies. Distinctive facial features and liver dysfunction usually present.

4. Holocarboxylase synthetase deficiency: Can cause spasticity, premature birth, neonatal death, and decreased carnitine. Ileus, effusions, and ferritin abnormalities less typical. Skin findings and severe metabolic acidosis often seen.

5. Menkes disease: Explains the spasticity, premature birth, neonatal death, and gastrointestinal symptoms. Low serum copper and ceruloplasmin levels are characteristic. Carnitine and vitamin B12 abnormalities are less common features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia Type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurologic crises. Can lead to early death if untreated. Patient's hypertyrosinemia is consistent, but liver and kidney involvement not mentioned.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Severe ""classic"" PKU can rarely lead to early death. Patient has hyperphenylalaninemia but no mention of developmental delay or disability.

3. Maple Syrup Urine Disease: Disorder of branched-chain amino acid metabolism leading to encephalopathy, coma, and death if untreated. Can cause recurrent infections. Key symptom of sweet-smelling urine not reported.

4. Biotinidase Deficiency: Causes neurologic symptoms, skin rash, and immunodeficiency. Can be fatal if untreated. Consistent with recurrent infections and early death, but characteristic skin rash not mentioned. 

5. Severe Combined Immunodeficiency (SCID): Group of disorders causing profound immunodeficiency and recurrent, often fatal infections in infancy. Consistent with patient's recurrent infections and early deaths, but metabolic abnormalities not typically seen.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Propionic acidemia: Fits the profile of an organic acidemia. Characterized by elevated glycine, propionic acid, and other carboxylic acids. Can present with lethargy, vomiting, failure to thrive, and early death if untreated.

2. Methylmalonic acidemia: Another organic acidemia that causes elevated glycine, methylmalonic acid, and other metabolites. Also associated with lethal disease in infancy as well as later-onset forms with varying severity. 

3. Isovaleric acidemia: Can cause the accumulation of isovaleric acid and other abnormal metabolites. Acute symptoms in the newborn period may include poor feeding, vomiting, lethargy, and rapid deterioration.

4. Glutaric acidemia type 1: Characterized by elevated glutaric acid, 3-hydroxyglutaric acid, and glutarylcarnitine. Can present with brain atrophy, macrocephaly, and dystonia in infants. Risk of striatal injury and encephalopathic crisis.

5. Multiple carboxylase deficiency: Group of disorders that disrupt the function of biotin-dependent carboxylases. Leads to elevated levels of multiple carboxylic acids. Can present with seizures, hypotonia, skin rash, and alopecia in addition to metabolic acidosis and organic aciduria.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Delayed speech and motor development, seizures, ataxia, hypotonia, and elevated urinary carboxylic acid (glutaric acid). Can present with metabolic stroke and brain atrophy.

2. Propionic acidemia: Developmental delay, seizures, hypotonia, hyperactivity, and elevated urinary carboxylic acid (3-hydroxypropionate). Can cause metabolic decompensation and early mortality.

3. Methylmalonic acidemia: Developmental delay, seizures, hypotonia, and elevated urinary carboxylic acid (methylmalonic acid). Can lead to metabolic crisis, neurological damage, and early death.

4. Canavan disease: Delayed development, seizures, hypotonia, and hyperactivity. Caused by aspartoacylase deficiency. MRI shows diffuse white matter degeneration.

5. Mitochondrial disorder: Global developmental delay, seizures, ataxia, hypotonia, and hyperactivity. Elevated lactate and organic acids. Varied presentations depending on specific mutation and organs involved.",Hereditary metabolic disorders
['Argininosuccinic aciduria'],"1. Fatty acid oxidation disorder: Consistent with tachycardia, metabolic acidosis, hepatomegaly, and early death. May also have hypoglycemia, which was not reported.

2. Organic acidemia (e.g., propionic acidemia, methylmalonic acidemia): Fits with tachypnea, vomiting, metabolic acidosis, and potential for infant death. Can also cause seizures and developmental delays.

3. Urea cycle disorder: Matches tachypnea, vomiting, and risk of neonatal death. Typically presents with hyperammonemia and encephalopathy.

4. Galactosemia: Accounts for vomiting, hepatomegaly, and risk of neonatal death if untreated. May also have jaundice, hypoglycemia, and cataracts.

5. Mitochondrial disorder: Can explain tachycardia, metabolic acidosis, hepatomegaly, and early death. Other features may include hypotonia, seizures, and lactic acidosis.",Hereditary metabolic disorders
['Gyrate atrophy of choroid and retina'],"1. Nonketotic hyperglycinemia: Consistent with hyperglycinemia, feeding difficulties, and early death. Other features like blindness and hyperammonemia can also occur. Does not explain the hypoargininemia or hyperornithinemia.

2. Ornithine transcarbamylase deficiency: A urea cycle defect that fits with the hyperammonemia, feeding problems, and risk of death in childhood. Protein aversion is common but not mentioned. Unclear if glycine and serine would be abnormal.

3. Homocystinuria: Features of this amino acid disorder include short stature, abnormal serine levels, feeding problems, and intellectual disability (not specifically mentioned). Anemia and vision problems can occur. Unclear if ammonia or other amino acids would be affected.

4. Hartnup disease: This disorder of amino acid transport is consistent with the short stature, malabsorption, and abnormal serine levels. Some cases have anemia. Usually not fatal in childhood. Other amino acid abnormalities would be expected.

5. Serine biosynthesis disorders: Fits with abnormal serine, feeding difficulties, and growth deficiency. Can be associated with microcephaly and intellectual disability. Vision loss is possible but less common. Unclear effects on other metabolites mentioned.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, failure to thrive, liver failure, renal dysfunction, and high risk of early death. The patient's neonatal/childhood death and hypertyrosinemia fit this diagnosis. Other symptoms not mentioned include skin/eye lesions and neurological issues.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability/developmental delay if untreated. Consistent with patient's hyperphenylalaninemia and abnormal development. Usually not fatal in infancy/childhood with modern diagnosis and treatment.

3. Maple syrup urine disease (MSUD): Leads to high levels of branched-chain amino acids and their ketoacids, causing a maple syrup odor in urine. Can present with neonatal encephalopathy, failure to thrive, and risk of infant death. Patient's neonatal death fits, but classic symptoms of sweet-smelling urine, lethargy, and seizures are not described.

4. Homocystinuria: Causes high homocysteine and methionine levels, developmental delay, visual problems, and skeletal abnormalities. Vascular events can cause early death. Some overlap with patient's symptoms but homocysteine/methionine not specifically mentioned.

5. Urea cycle disorders (e.g. OTC deficiency): Lead to hyperammonemia, encephalopathy, coma, and death, often triggered by high protein intake or stress. Could explain infant/childhood death but characteristic symptoms of vomiting, lethargy, coma not noted, and involves nitrogen metabolism rather than tyrosine or phenylalanine specifically.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Urea cycle disorder: Hyperammonemia, cerebral edema, apathy/lethargy, hypotonia, feeding difficulties, and death in infancy can be seen. Respiratory alkalosis is often present but not reported here.

2. Organic acidemia (e.g. propionic, methylmalonic): Hypotonia, poor feeding, lethargy, hyperammonemia, and neonatal death can occur. Metabolic acidosis and ketosis are usually seen as well.

3. Pyruvate dehydrogenase deficiency: Hypotonia, lethargy, feeding problems, and cerebral edema can be present. Lactic acidosis and seizures are common features not mentioned.

4. Zellweger syndrome (a peroxisomal disorder): Profound hypotonia, poor feeding, and neonatal death are typical. Distinctive facial features and liver dysfunction are usually present too.

5. Molybdenum cofactor deficiency: Neonatal seizures, hypotonia, feeding difficulties, and death in early infancy are characteristic. High sulfite levels and dislocated lenses are often seen but not reported.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Rare inherited disorder that damages the ability of nerve cells to send and receive messages. Consistent with patient's blindness, seizures, hypotonia, motor delays, hearing loss and early death. Caused by aspartoacylase deficiency leading to buildup of N-acetylaspartic acid.

2. Maple syrup urine disease: Inherited disorder preventing the body from processing certain amino acids, leading to a toxic buildup. Matches patient's seizures, hypotonia, opisthotonus, and high levels of aspartate amino acids. Can be fatal in infancy if untreated. Patient did not have the characteristic sweet-smelling urine.

3. Phenylketonuria (PKU): Inherited disorder causing a buildup of phenylalanine which can damage the brain. Explains developmental delays, seizures and hypotonia. Usually also see eczema, small head size and light skin/hair, which patient did not have. 

4. Sulfite oxidase deficiency: Rare inherited metabolic disorder disrupting the nervous system. Matches seizures, motor delays, opisthotonus and early death. Also characterized by dislocation of the lenses of the eyes, not seen in this patient.

5. Menkes disease: Disorder of copper metabolism affecting the nervous system. Consistent with seizures, hypotonia, developmental delays and early death. Patients also have sparse, kinky hair and bony abnormalities, which were not noted here.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","1. Methylmalonic acidemia with homocystinuria (cblC type): Hydrocephalus, microcephaly, intellectual disability, early death, hyperhomocystinemia, methylmalonic aciduria, abnormal carnitine. May also have retinopathy and seizures.

2. Zellweger spectrum disorder: Hydrocephalus, intellectual disability, hypotonia, early death, abnormal eye movements, abnormal carnitine. Typically have liver dysfunction and characteristic facial features.

3. Walker-Warburg syndrome: Hydrocephalus, microcephaly, intellectual disability, eye abnormalities, early death, hypotonia, seizures. Brain MRI shows cobblestone lissencephaly and cerebellar malformation.  

4. Pyruvate dehydrogenase deficiency: Intellectual disability, microcephaly, hypotonia, dyskinesia, lactic acidosis, early death. MRI may show corpus callosum agenesis and ventriculomegaly.

5. Menkes disease: Intellectual disability, microcephaly, hypotonia, seizures, abnormal eye movements, premature birth, early death. Characteristically have sparse, kinky hair and hypothermia. May have subdural hematomas.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Abnormal carnitine level, decreased 3-hydroxyacyl-CoA dehydrogenase, vomiting, risk of sudden infant death. Key feature not reported: hypoglycemia.

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Decreased 3-hydroxyacyl-CoA dehydrogenase, abnormal prenatal development, gastrointestinal symptoms, risk of early death. Additional feature: hypoglycemia, liver problems.

3. Carnitine uptake defect (primary carnitine deficiency): Abnormally low carnitine levels, risk of infant death, gastrointestinal symptoms. Key features not reported: cardiomyopathy, hypoglycemia.

4. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Abnormal prenatal development, decreased 3-hydroxyacyl-CoA dehydrogenase, vomiting, risk of early death. Other features: hypoglycemia, cardiomyopathy, liver problems.

5. Trifunctional protein deficiency: Decreased 3-hydroxyacyl-CoA dehydrogenase, abnormal prenatal development, gastrointestinal symptoms, high risk of neonatal death. Can also cause: cardiomyopathy, liver dysfunction, hypoglycemia.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with generalized hypotonia, leukopenia, metabolic acidosis, hyperammonemia, and early death. May also have ketoacidosis and cardiomyopathy.

2. Methylmalonic acidemia: Presents with generalized hypotonia, metabolic acidosis, hyperammonemia, and early death. May also have pancytopenia, seizures, and renal failure.  

3. Isovaleric acidemia: Features generalized hypotonia, leukopenia, metabolic acidosis, and hyperammonemia. The ""sweaty feet"" odor is characteristic but not always present in neonates.

4. Ornithine transcarbamylase deficiency: A urea cycle defect causing hyperammonemia, lethargy progressing to coma, and early death. Metabolic acidosis and leukopenia can occur. More common in males.

5. Pyruvate dehydrogenase complex deficiency: Can present with hypotonia, lactic acidosis, and hyperammonemia. Leukopenia is less common. May also have seizures and structural brain abnormalities.",Hereditary metabolic disorders
['Tyrosinemia type 2'],"1. Tyrosinemia type II: This rare genetic disorder is characterized by hypertyrosinemia, eye and skin symptoms as seen in this patient. Intellectual disability and neurological symptoms can also occur.

2. Tyrosinemia type I: Another disorder of tyrosine metabolism, type I often has more severe symptoms including liver failure and renal dysfunction, which were not reported in this patient. 

3. Richner-Hanhart syndrome (tyrosinemia type II): This is an alternate name for tyrosinemia type II and matches the patient's presentation.

4. Alkaptonuria: Another genetic disorder of tyrosine metabolism. It typically causes darkening of the urine and arthritis rather than the neurological and eye symptoms seen here.

5. Keratitis-ichthyosis-deafness (KID) syndrome: This rare condition can cause eye and skin symptoms similar to this patient. However, the hypertyrosinemia and intellectual disability would not be explained.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Caused by phenylalanine hydroxylase deficiency. Consistent with hyperphenylalaninemia, abnormal tyrosine levels, and abnormal prenatal development. Can lead to early death if untreated.

2. Tyrosinemia type I: Caused by fumarylacetoacetate hydrolase deficiency. Matches abnormal tyrosine levels and can be fatal in infancy or early childhood if untreated. 

3. Alkaptonuria: Disrupts tyrosine degradation due to homogentisate 1,2-dioxygenase deficiency. Fits abnormal tyrosine levels but usually has normal lifespan, making it less likely here.

4. Maple syrup urine disease: Impairs breakdown of branched-chain amino acids. Could explain abnormal prenatal development and early death but does not typically involve phenylalanine/tyrosine pathways.

5. Glutaric acidemia type I: Interferes with lysine and tryptophan metabolism. Associated with abnormal development and can be fatal in childhood but does not classically present with hyperphenylalaninemia or abnormal tyrosine.",Hereditary metabolic disorders
[],"1. Propionic acidemia: Consistent with hyperammonemia, 3-hydroxydicarboxylic aciduria, seizures, and potential for infant death if untreated. Other symptoms may include poor feeding, vomiting, and lethargy.

2. Methylmalonic acidemia: Also features hyperammonemia, 3-hydroxydicarboxylic aciduria, seizures, and risk of neonatal death. Patients may also exhibit metabolic acidosis, neutropenia, and developmental delays.

3. Isovaleric acidemia: Can present with hyperammonemia, acidosis, seizures, and cyanosis in severe cases. The characteristic ""sweaty feet"" odor was not mentioned here.

4. Glutaric acidemia type 2: Associated with metabolic acidosis, 3-hydroxydicarboxylic aciduria, hypoglycemia, and risk of infant death. Patients often have distinctive facial features and liver dysfunction.

5. Ornithine transcarbamylase deficiency: A urea cycle defect leading to hyperammonemia, seizures, and potential neonatal death, especially in severe cases. Cyanosis is atypical but may occur with respiratory distress.",Hereditary metabolic disorders
['Alkaptonuria'],"1. Galactosemia: vomiting, failure to thrive, dark urine; jaundice and cataracts may also occur

2. Tyrosinemia type 1: vomiting, failure to thrive, dark urine, jaundice, liver dysfunction; neurologic symptoms and rickets may develop later

3. Biliary atresia: dark urine, jaundice, pale stools, vomiting, failure to thrive; enlarged liver and spleen

4. Neonatal sepsis: vomiting, temperature instability, lethargy, poor feeding, dark urine (if kidneys involved); jaundice and rash may be present

5. Urea cycle disorder: vomiting, lethargy, failure to thrive, dark urine; seizures and respiratory alkalosis in severe cases",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Consistent with patient's seizures, lethargy, growth delay, metabolic acidosis, hyperammonemia, feeding difficulties, and elevated branched-chain amino acids (valine, leucine, isoleucine). Can cause severe complications like intellectual disability and death if untreated.

2. Propionic acidemia: Could explain lethargy, growth delay, metabolic acidosis, hyperammonemia, and feeding issues. However, specific branched-chain amino acid elevations are more suggestive of MSUD. 

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with lethargy, growth delay, metabolic acidosis, and hyperammonemia. Less likely than MSUD given amino acid profile.

4. Isovaleric acidemia: Can present with lethargy, feeding problems, and metabolic acidosis. However, patient's amino acid abnormalities are not typical of this condition.

5. Urea cycle disorder (e.g. ornithine transcarbamylase deficiency): Hyperammonemia and lethargy would fit, but seizures, specific branched-chain amino acid elevations, and hearing impairment are less commonly seen.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's hyperammonemia, encephalopathy, cerebral edema, hypotonia, vomiting, and early mortality. The absence of respiratory alkalosis and normal citrulline are atypical.

2. Citrullinemia type I: The elevated citrulline, hyperammonemia, encephalopathy, cerebral edema, and early death fit. However, the patient's proline and arginine abnormalities are not typical of citrullinemia.

3. Propionic acidemia: Could explain the patient's hypotonia, vomiting, hypoglycemia, hyperammonemia, and early mortality. Dermatitis is atypical. Urine organic acids and acylcarnitine profile would help evaluate for this.

4. Methylmalonic acidemia: Similar to propionic acidemia, matches the neurologic and metabolic abnormalities but the skin findings are unusual. Methylmalonic acid levels would be elevated.

5. Mitochondrial depletion syndrome: A rare possibility that could tie together the multi-system involvement with neurologic, cardiac, metabolic, GI, and immune dysfunction. Specific genetic testing would be required.",Hereditary metabolic disorders
